<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Cimetidine</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Cimetidine">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Cimetidine</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Cimetidine</b>, sold under the brand name <b>Tagamet</b> among others, is a <a href="Histamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Histamine" title="Histamine">histamine</a> H<sub>2</sub> receptor antagonist that inhibits stomach acid production.<span class="mw-ref" id="cite_ref-Elks2014_1-1"><a href="#cite_note-Elks2014-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-IndexNominum2000_7-0"><a href="#cite_note-IndexNominum2000-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-MortonMorton1999_8-0"><a href="#cite_note-MortonMorton1999-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> It is mainly used in the treatment of heartburn and peptic ulcers.<span class="mw-ref" id="cite_ref-Elks2014_1-2"><a href="#cite_note-Elks2014-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-MortonMorton1999_8-1"><a href="#cite_note-MortonMorton1999-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-BurchumRosenthal2014_9-0"><a href="#cite_note-BurchumRosenthal2014-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span></p>


<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Cimetidine</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Cimetidine_Structural_Formula_V.1.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Cimetidine_Structural_Formula_V.1.svg.png" data-file-width="601" data-file-height="225" data-file-type="drawing" height="94" width="250"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Cimetidine-xtal-3D-balls.png" tppabs="https://ptable.com/wiki/compounds/I/m/Cimetidine-xtal-3D-balls.png" data-file-width="1100" data-file-height="667" data-file-type="bitmap" height="152" width="250"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pronunciation</th><td><span class="rt-commentedText nowrap"><span class="IPA nopopups noexcerpt">/<span style="border-bottom:1px dotted"><span>s</span><span>ɪ</span><span>ˈ</span><span>m</span><span>ɛ</span><span>t</span><span>ɪ</span><span>d</span><span>iː</span><span>n</span></span>/</span></span> or <span class="rt-commentedText nowrap"><span class="IPA nopopups noexcerpt">/<span style="border-bottom:1px dotted"><span>s</span><span>aɪ</span><span>ˈ</span><span>m</span><span>ɛ</span><span>t</span><span>ɪ</span><span>d</span><span>iː</span><span>n</span></span>/</span></span><span> </span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Tagamet, others</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Other names</th><td>SKF-92334<span class="mw-ref" id="cite_ref-Elks2014_1-0"><a href="#cite_note-Elks2014-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/cimetidine.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/cimetidine.html'" tppabs="https://www.drugs.com/monograph/cimetidine.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a682256.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a682256.html'" tppabs="https://medlineplus.gov/druginfo/meds/a682256.html" class="external text external">a682256</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span><span>FDA:<span>&nbsp;</span><a href="javascript:if(confirm('https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Cimetidine&SearchType=BasicSearch  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Cimetidine&SearchType=BasicSearch'" tppabs="https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Cimetidine&SearchType=BasicSearch" class="external text external">Cimetidine</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>B1<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>B (No risk in non-human studies)<span> </span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth, intramuscular injection, intravenous infusion<span class="mw-ref" id="cite_ref-GuptaSingh-Radcliff2013_2-0"><a href="#cite_note-GuptaSingh-Radcliff2013-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>A02BA01<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=A02BA01  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=A02BA01'" tppabs="https://www.whocc.no/atc_ddd_index/?code=A02BA01" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>S4 (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">UK</abbr>:</small><span> </span>POM (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>℞-only<span> </span>(although 200 mg is OTC)</li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>60–70%<span class="mw-ref" id="cite_ref-DowdJohnson2016_3-0"><a href="#cite_note-DowdJohnson2016-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-LeikinPaloucek1995_4-0"><a href="#cite_note-LeikinPaloucek1995-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>13–25%<span class="mw-ref" id="cite_ref-LeikinPaloucek1995_4-1"><a href="#cite_note-LeikinPaloucek1995-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-AcademicPress1984_5-0"><a href="#cite_note-AcademicPress1984-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Liver<span class="mw-ref" id="cite_ref-LeikinPaloucek1995_4-2"><a href="#cite_note-LeikinPaloucek1995-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolites</th><td>• Cimetidine sulfoxide<span class="mw-ref" id="cite_ref-LeikinPaloucek1995_4-3"><a href="#cite_note-LeikinPaloucek1995-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><br>• Hydroxycimetidine<span class="mw-ref" id="cite_ref-LeikinPaloucek1995_4-4"><a href="#cite_note-LeikinPaloucek1995-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><br>• Guanyl urea cimetidine<span class="mw-ref" id="cite_ref-LeikinPaloucek1995_4-5"><a href="#cite_note-LeikinPaloucek1995-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Onset of action</th><td>30 minutes<span class="mw-ref" id="cite_ref-VallerandSanoski2016_6-0"><a href="#cite_note-VallerandSanoski2016-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>123 minutes (~2 hours)<span class="mw-ref" id="cite_ref-AcademicPress1984_5-1"><a href="#cite_note-AcademicPress1984-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Duration of action</th><td>4–8 hours<span class="mw-ref" id="cite_ref-GuptaSingh-Radcliff2013_2-1"><a href="#cite_note-GuptaSingh-Radcliff2013-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Urine<span class="mw-ref" id="cite_ref-AcademicPress1984_5-2"><a href="#cite_note-AcademicPress1984-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">1-cyano-2-methyl-3-[2-[(5-methyl-1<i>H</i>-imidazol-4-yl)methylsulfanyl]ethyl]guanidine</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=51481-61-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=51481-61-9'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=51481-61-9" class="external text external">51481-61-9</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/2756  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/2756'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/2756" class="external text external">2756</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1231  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1231'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1231" class="external text external">1231</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00501  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00501'" tppabs="https://www.drugbank.ca/drugs/DB00501" class="external text external">DB00501</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.2654.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.2654.html'" tppabs="http://www.chemspider.com/Chemical-Structure.2654.html" class="external text external">2654</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=80061L1WGD  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=80061L1WGD'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=80061L1WGD" class="external text external">80061L1WGD</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D00295  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D00295'" tppabs="https://www.kegg.jp/entry/D00295" class="external text external">D00295</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:3699  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:3699'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:3699" class="external text external">CHEBI:3699</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL30  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL30'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL30" class="external text external">ChEMBL30</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID4020329  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID4020329'" tppabs="https://comptox.epa.gov/dashboard/DTXSID4020329" class="external text external">DTXSID4020329</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.052.012  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.052.012'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.052.012" class="external text external">100.052.012</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>10</sub><span>H</span><sub>16</sub><span>N</span><sub>6</sub><span>S</span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">252.34</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=CC1%3DC%28N%3DCN1%29CSCCNC%28%3DNC%29NC%23N  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=CC1%3DC%28N%3DCN1%29CSCCNC%28%3DNC%29NC%23N'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=CC1%3DC%28N%3DCN1%29CSCCNC%28%3DNC%29NC%23N" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">CC1=C(N=CN1)CSCCNC(=NC)NC#N</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C10H16N6S/c1-8-9(16-7-15-8)5-17-4-3-13-10(12-2)14-6-11/h7H,3-5H2,1-2H3,(H,15,16)(H2,12,13,14)<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:AQIXAKUUQRKLND-UHFFFAOYSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=456484490&page2=Cimetidine  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=456484490&page2=Cimetidine'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=456484490&page2=Cimetidine" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

<p>The development of longer-acting H<sub>2</sub> receptor antagonists with fewer drug interactions and adverse effects, such as <a href="Ranitidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ranitidine" title="Ranitidine">ranitidine</a> and <a href="Famotidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Famotidine" title="Famotidine">famotidine</a>, decreased the use of cimetidine, and though it is still used, cimetidine is no longer among the more widely used of the H<sub>2</sub> receptor antagonists.</p>


<p>Cimetidine was developed in 1971 and came into commercial use in 1977.<span class="mw-ref" id="cite_ref-FischerGanellin2010_10-0"><a href="#cite_note-FischerGanellin2010-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-11"><a href="#cite_note-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> Cimetidine was approved in the United Kingdom in 1976, and was approved in the United States by the Food and Drug Administration for prescriptions in 1979.<span class="mw-ref" id="cite_ref-12"><a href="#cite_note-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>

<style data-mw-deduplicate="TemplateStyles:r886046785">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class="toclimit-3"><meta property="mw:PageProp/toc"></div>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    


<p>Cimetidine is used to inhibit stomach acid production and is used in the treatment of heartburn and peptic ulcers.</p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Other_uses">Other uses</h3></summary>
    
<p>Some evidence suggests cimetidine could be effective in the treatment of common warts, but more rigorous double-blind clinical trials found it to be no more effective than a placebo.<span class="mw-ref" id="cite_ref-13"><a href="#cite_note-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span><span class="mw-ref" id="cite_ref-14"><a href="#cite_note-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span><span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></p>

<p>Tentative evidence supports a beneficial role as add-on therapy in colorectal cancer.<span class="mw-ref" id="cite_ref-16"><a href="#cite_note-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>

<p>Cimetidine inhibits ALA synthase activity and hence may have some therapeutic value in preventing and treating acute porphyria attacks.<span class="mw-ref" id="cite_ref-17"><a href="#cite_note-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span><span class="mw-ref" id="cite_ref-18"><a href="#cite_note-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>

<p>There is some evidence supporting the use of Cimetidine in the treatment of PFAPA<span class="mw-ref" id="cite_ref-ped-rheum_19-0"><a href="#cite_note-ped-rheum-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span>.</p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Side_effects">Side effects</h2></summary>
    
<p>Reported side effects of cimetidine include diarrhea, rashes, dizziness, fatigue, constipation, and muscle pain, all of which are usually mild and transient.<span class="mw-ref" id="cite_ref-RitterLewis2008_20-0"><a href="#cite_note-RitterLewis2008-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span> It has been reported that mental confusion may occur in the elderly.<span class="mw-ref" id="cite_ref-RitterLewis2008_20-1"><a href="#cite_note-RitterLewis2008-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span> Because of its hormonal effects, cimetidine rarely may cause sexual dysfunction including loss of libido and erectile dysfunction and gynecomastia (0.1–0.2%) in males during long-term treatment.<span class="mw-ref" id="cite_ref-RitterLewis2008_20-2"><a href="#cite_note-RitterLewis2008-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span><span class="mw-ref" id="cite_ref-21"><a href="#cite_note-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span><span class="mw-ref" id="cite_ref-22"><a href="#cite_note-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span> Rarely, interstitial nephritis, urticaria, and angioedema have been reported with cimetidine treatment.<span class="mw-ref" id="cite_ref-RitterLewis2008_20-3"><a href="#cite_note-RitterLewis2008-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span> Cimetidine is also commonly associated with transient raised aminotransferase activity; hepatotoxicity is rare.<span class="mw-ref" id="cite_ref-Kelly2009_23-0"><a href="#cite_note-Kelly2009-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Overdose">Overdose</h2></summary>
    
<p>Cimetidine appears to be very safe in overdose, producing no symptoms even with massive overdoses (e.g., 20 g).<span class="mw-ref" id="cite_ref-Dart2004_24-0"><a href="#cite_note-Dart2004-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Interactions">Interactions</h2></summary>
    
<p>Due to its non-selective inhibition of cytochrome P450 enzymes, cimetidine has numerous drug interactions. Examples of specific interactions include the following:</p>

<ul><li>Cimetidine affects the metabolism of <a href="Methadone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methadone" title="Methadone">methadone</a>, sometimes resulting in higher blood levels and a higher incidence of side effects, and may interact with the antimalarial medication <a href="Hydroxychloroquine.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydroxychloroquine" title="Hydroxychloroquine">hydroxychloroquine</a>.<span class="mw-ref" id="cite_ref-25"><a href="#cite_note-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span></li>
<li>Cimetidine can also interact with a number of psychoactive medications, including tricyclic antidepressants and selective serotonin reuptake inhibitors, causing increased blood levels of these drugs and the potential of subsequent toxicity.</li>
<li>Following administration of cimetidine, the elimination half-life and area-under-curve of <a href="Zolmitriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Zolmitriptan" title="Zolmitriptan">zolmitriptan</a> and its active metabolites were roughly doubled.<span class="mw-ref" id="cite_ref-26"><a href="#cite_note-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span></li>
<li>Cimetidine is a potent inhibitor of tubular <a href="Creatinine.htm" tppabs="https://ptable.com/wiki/compounds/A/Creatinine" title="Creatinine">creatinine</a> secretion. Creatinine is a metabolic byproduct of <a href="Creatine.htm" tppabs="https://ptable.com/wiki/compounds/A/Creatine" title="Creatine">creatine</a> breakdown. Accumulation of creatinine is associated with uremia, but the symptoms of creatinine accumulation are unknown, as they are hard to separate from other nitrogenous waste buildups.<span class="mw-ref" id="cite_ref-27"><a href="#cite_note-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span></li>
<li>Like several other medications (e.g. <a href="Erythromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Erythromycin" title="Erythromycin">erythromycin</a>), cimetidine interferes with the body's metabolization of <a href="Sildenafil.htm" tppabs="https://ptable.com/wiki/compounds/A/Sildenafil" title="Sildenafil">sildenafil</a>, causing its strength and duration to increase (therefore also its side effects to be more likely and prominent).</li>
<li>Clinically significant drug interactions with the CYP1A2 substrate <a href="Theophylline.htm" tppabs="https://ptable.com/wiki/compounds/A/Theophylline" title="Theophylline">theophylline</a>, the CYP2C9 substrate <a href="Tolbutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Tolbutamide" title="Tolbutamide">tolbutamide</a>, the CYP2D6 substrate desipramine, and the CYP3A4 substrate <a href="Triazolam.htm" tppabs="https://ptable.com/wiki/compounds/A/Triazolam" title="Triazolam">triazolam</a> have all been demonstrated with cimetidine, and interactions with other substrates of these enzymes are likely as well.<span class="mw-ref" id="cite_ref-Rodrigues2008_28-0"><a href="#cite_note-Rodrigues2008-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span></li>
<li>Cimetidine has been shown clinically to reduce the clearance of <a href="Mirtazapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mirtazapine" title="Mirtazapine">mirtazapine</a>, <a href="Imipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Imipramine" title="Imipramine">imipramine</a>, <a href="Timolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Timolol" title="Timolol">timolol</a>, nebivolol, sparteine, <a href="Loratadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Loratadine" title="Loratadine">loratadine</a>, <a href="Nortriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Nortriptyline" title="Nortriptyline">nortriptyline</a>, <a href="Gabapentin.htm" tppabs="https://ptable.com/wiki/compounds/A/Gabapentin" title="Gabapentin">gabapentin</a>, and desipramine in humans.<span class="mw-ref" id="cite_ref-Zhou2016_29-0"><a href="#cite_note-Zhou2016-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></li>
<li>Cimetidine inhibits the renal excretion of <a href="Metformin.htm" tppabs="https://ptable.com/wiki/compounds/A/Metformin" title="Metformin">metformin</a> and <a href="Procainamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Procainamide" title="Procainamide">procainamide</a>, resulting in increased circulating levels of these drugs.<span class="mw-ref" id="cite_ref-RitterLewis2008_20-4"><a href="#cite_note-RitterLewis2008-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span></li>
<li>Interactions of potential clinical importance with cimetidine include <a href="Warfarin.htm" tppabs="https://ptable.com/wiki/compounds/A/Warfarin" title="Warfarin">warfarin</a>, <a href="Theophylline.htm" tppabs="https://ptable.com/wiki/compounds/A/Theophylline" title="Theophylline">theophylline</a>, <a href="Phenytoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenytoin" title="Phenytoin">phenytoin</a>, <a href="Carbamazepine.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbamazepine" title="Carbamazepine">carbamazepine</a>, <a href="Pethidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pethidine" title="Pethidine">pethidine</a> and other opioid analgesics, tricyclic antidepressants, <a href="Lidocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lidocaine" title="Lidocaine">lidocaine</a>, <a href="Terfenadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Terfenadine" title="Terfenadine">terfenadine</a>, <a href="Amiodarone.htm" tppabs="https://ptable.com/wiki/compounds/A/Amiodarone" title="Amiodarone">amiodarone</a>, <a href="Flecainide.htm" tppabs="https://ptable.com/wiki/compounds/A/Flecainide" title="Flecainide">flecainide</a>, <a href="Quinidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinidine" title="Quinidine">quinidine</a>, <a href="Fluorouracil.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluorouracil" title="Fluorouracil">fluorouracil</a>, and benzodiazepines.<span class="mw-ref" id="cite_ref-RitterLewis2008_20-5"><a href="#cite_note-RitterLewis2008-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span><span class="mw-ref" id="cite_ref-RosenfeldLoose2007_30-0"><a href="#cite_note-RosenfeldLoose2007-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span></li>
<li>Cimetidine may decrease the effects of CYP2D6 substrates that are prodrugs, such as <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Codeine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Codeine'" tppabs="https://ptable.com/wiki/compounds/A/Codeine" title="Codeine">codeine</a>, <a href="Tramadol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tramadol" title="Tramadol">tramadol</a>, and <a href="Tamoxifen.htm" tppabs="https://ptable.com/wiki/compounds/A/Tamoxifen" title="Tamoxifen">tamoxifen</a>.<span class="mw-ref" id="cite_ref-FullerSajatovic2005_31-0"><a href="#cite_note-FullerSajatovic2005-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span></li>
<li>Cimetidine reduces the absorption of <a href="Ketoconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketoconazole" title="Ketoconazole">ketoconazole</a> and <a href="Itraconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Itraconazole" title="Itraconazole">itraconazole</a> (which require a low pH).<span class="mw-ref" id="cite_ref-RitterLewis2008_20-6"><a href="#cite_note-RitterLewis2008-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span></li>
<li>Cimetidine has a theoretical but unproven benefit in paracetamol toxicity.<span class="mw-ref" id="cite_ref-Kelly2009_23-1"><a href="#cite_note-Kelly2009-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> This is because N-acetyl-p-benzoquinone imine (NAPQI), a metabolite of <a href="Paracetamol.htm" tppabs="https://ptable.com/wiki/compounds/A/Paracetamol" title="Paracetamol">paracetamol</a> (acetaminophen) that is responsible for its hepatotoxicity, is formed from it by the cytochrome P450 system (specifically, CYP1A2, CYP2E1, and CYP3A4).<span class="mw-ref" id="cite_ref-CameronFeuer2012_32-0"><a href="#cite_note-CameronFeuer2012-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span></li>
<li>Numerous other drug interactions.</li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacodynamics">Pharmacodynamics</h3></summary>
    


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Histamine_H2_receptor_antagonism">Histamine H<sub>2</sub> receptor antagonism</h4></summary>
    
<p>The mechanism of action of cimetidine as an antacid is as a <a href="Histamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Histamine" title="Histamine">histamine</a> H<sub>2</sub> receptor antagonist.<span class="mw-ref" id="cite_ref-pmid6317740_33-0"><a href="#cite_note-pmid6317740-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span> It has been found to bind to the H<sub>2</sub> receptor with a K<sub>d</sub> of 42<span>&nbsp;</span>nM.<span class="mw-ref" id="cite_ref-Osborne2013_34-0"><a href="#cite_note-Osborne2013-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Cytochrome_P450_inhibition">Cytochrome P450 inhibition</h4></summary>
    
<p>Cimetidine is a potent inhibitor of certain cytochrome P450 (CYP450) enzymes,<span class="mw-ref" id="cite_ref-Dart2004_24-1"><a href="#cite_note-Dart2004-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span><span class="mw-ref" id="cite_ref-LemkeWilliams2008_35-0"><a href="#cite_note-LemkeWilliams2008-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span> including CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4.<span class="mw-ref" id="cite_ref-Dart2004_24-2"><a href="#cite_note-Dart2004-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span><span class="mw-ref" id="cite_ref-LemkeWilliams2008_35-1"><a href="#cite_note-LemkeWilliams2008-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span><span class="mw-ref" id="cite_ref-KarallieddeClarke2010_36-0"><a href="#cite_note-KarallieddeClarke2010-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span> The drug appears to primarily inhibit CYP1A2, CYP2D6, and CYP3A4,<span class="mw-ref" id="cite_ref-PriskornLarsen1997_37-0"><a href="#cite_note-PriskornLarsen1997-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span> of which it is described as a moderate inhibitor.<span class="mw-ref" id="cite_ref-VallerandSanoski2016_6-1"><a href="#cite_note-VallerandSanoski2016-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> This is notable since these three CYP450 isoenzymes are involved in CYP450-mediated drug biotransformations;<span class="mw-ref" id="cite_ref-MartinezAlbet1999_38-0"><a href="#cite_note-MartinezAlbet1999-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> however, CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4 are also involved in the oxidative metabolism of many commonly used drugs.<span class="mw-ref" id="cite_ref-Delafuente2003_39-0"><a href="#cite_note-Delafuente2003-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span> As a result, cimetidine has the potential for a large number of pharmacokinetic interactions.<span class="mw-ref" id="cite_ref-Dart2004_24-3"><a href="#cite_note-Dart2004-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span><span class="mw-ref" id="cite_ref-LemkeWilliams2008_35-2"><a href="#cite_note-LemkeWilliams2008-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span><span class="mw-ref" id="cite_ref-KarallieddeClarke2010_36-1"><a href="#cite_note-KarallieddeClarke2010-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span></p>

<p>Cimetidine is reported to be a competitive and reversible inhibitor of several CYP450 enzymes,<span class="mw-ref" id="cite_ref-Kelly2009_23-2"><a href="#cite_note-Kelly2009-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span><span class="mw-ref" id="cite_ref-RosenfeldLoose2007_30-1"><a href="#cite_note-RosenfeldLoose2007-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span><span class="mw-ref" id="cite_ref-LemkeWilliams2008_35-3"><a href="#cite_note-LemkeWilliams2008-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span><span class="mw-ref" id="cite_ref-Cairns2012_40-0"><a href="#cite_note-Cairns2012-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span> although mechanism-based (suicide) irreversible inhibition has also been identified for cimetidine's inhibition of CYP2D6.<span class="mw-ref" id="cite_ref-Zhou2016_29-1"><a href="#cite_note-Zhou2016-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span> It reversibly inhibits CYP450 enzymes by binding directly with the complexed <a href="Heme.htm" tppabs="https://ptable.com/wiki/compounds/A/Heme" title="Heme">heme</a>-<a href="Iron.htm" tppabs="https://ptable.com/wiki/compounds/A/Iron" title="Iron">iron</a> of the active site via one of its <a href="Imidazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Imidazole" title="Imidazole">imidazole</a> ring <a href="Nitrogen.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitrogen" title="Nitrogen">nitrogen</a> atoms, thereby blocking the oxidation of other drugs.<span class="mw-ref" id="cite_ref-LemkeWilliams2008_35-4"><a href="#cite_note-LemkeWilliams2008-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span><span class="mw-ref" id="cite_ref-Cairns2012_40-1"><a href="#cite_note-Cairns2012-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span><span class="mw-ref" id="cite_ref-pmid9630736_41-0"><a href="#cite_note-pmid9630736-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Antiandrogenic_and_estrogenic_effects">Antiandrogenic and estrogenic effects</h4></summary>
    
<p>Cimetidine has been found to possess weak antiandrogenic activity at high doses.<span class="mw-ref" id="cite_ref-pmid6317740_33-1"><a href="#cite_note-pmid6317740-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span><span class="mw-ref" id="cite_ref-Becker2001_42-0"><a href="#cite_note-Becker2001-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span><span class="mw-ref" id="cite_ref-pmid6150641_43-0"><a href="#cite_note-pmid6150641-43" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span><span class="mw-ref" id="cite_ref-pmid3921876_44-0"><a href="#cite_note-pmid3921876-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span> It directly and competitively antagonizes the androgen receptor (AR), the biological target of androgens like <a href="Testosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testosterone" title="Testosterone">testosterone</a> and <a href="Dihydrotestosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydrotestosterone" title="Dihydrotestosterone">dihydrotestosterone</a> (DHT).<span class="mw-ref" id="cite_ref-pmid428705_45-0"><a href="#cite_note-pmid428705-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span><span class="mw-ref" id="cite_ref-pmid6123322_46-0"><a href="#cite_note-pmid6123322-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span> However, the affinity of cimetidine for the AR is very weak; in one study, it showed only 0.00084% of the affinity of the anabolic steroid <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Metribolone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Metribolone'" tppabs="https://ptable.com/wiki/compounds/A/Metribolone" title="Metribolone">metribolone</a> (100%) for the human AR (K<sub>i</sub> = 140<span>&nbsp;</span>μM and 1.18<span>&nbsp;</span>nM, respectively).<span class="mw-ref" id="cite_ref-pmid6725525_b_47-0"><a href="#cite_note-pmid6725525_b-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span> In any case, at sufficiently high doses, cimetidine has demonstrated weak but significant antiandrogenic effects in animals, including antiandrogenic effects in the rat ventral prostate and mouse kidney, reductions in the weights of the male accessory glands like the prostate gland and seminal vesicles in rats, and elevated gonadotropin levels in male rats (due to reduced negative feedback on the <abbr>HPG</abbr> axis by androgens).<span class="mw-ref" id="cite_ref-GerallMoltz2013_48-0"><a href="#cite_note-GerallMoltz2013-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span><span class="mw-ref" id="cite_ref-PlessisAgarwal2014_49-0"><a href="#cite_note-PlessisAgarwal2014-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span> In addition to AR antagonism, cimetidine has been found to inhibit the 2-hydroxylation of <a href="Estradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estradiol" title="Estradiol">estradiol</a> (via inhibition of CYP450 enzymes, which are involved in the metabolic inactivation of estradiol), resulting in increased <a href="Estrogen.htm" tppabs="https://ptable.com/wiki/compounds/A/Estrogen" title="Estrogen">estrogen</a> levels.<span class="mw-ref" id="cite_ref-GalbraithMichnovicz1989_50-0"><a href="#cite_note-GalbraithMichnovicz1989-50" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span><span class="mw-ref" id="cite_ref-pmid1988774_51-0"><a href="#cite_note-pmid1988774-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span><span class="mw-ref" id="cite_ref-PescovitzWalvoord2007_52-0"><a href="#cite_note-PescovitzWalvoord2007-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span><span class="mw-ref" id="cite_ref-PolatCuhaci2014_53-0"><a href="#cite_note-PolatCuhaci2014-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span><span class="mw-ref" id="cite_ref-RendicCarlo2010_54-0"><a href="#cite_note-RendicCarlo2010-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span><span class="mw-ref" id="cite_ref-GalbraithMichnovicz1989_50-1"><a href="#cite_note-GalbraithMichnovicz1989-50" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span> The medication has also been reported to reduce testosterone biosynthesis and increase prolactin levels in individual case reports, effects which might be secondary to increased estrogen levels.<span class="mw-ref" id="cite_ref-pmid22862307_55-0"><a href="#cite_note-pmid22862307-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span></p>

<p>At typical therapeutic levels, cimetidine has either no effect on or causes small increases in circulating testosterone concentrations in men.<span class="mw-ref" id="cite_ref-GerallMoltz2013_48-1"><a href="#cite_note-GerallMoltz2013-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span> Any increases in testosterone levels with cimetidine have been attributed to the loss of negative feedback on the HPG axis that results due to AR antagonism.<span class="mw-ref" id="cite_ref-GerallMoltz2013_48-2"><a href="#cite_note-GerallMoltz2013-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span><span class="mw-ref" id="cite_ref-PlessisAgarwal2014_49-1"><a href="#cite_note-PlessisAgarwal2014-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span> At typical clinical dosages, such as those used to treat peptic ulcer disease, the incidence of gynecomastia (breast development) with cimetidine is very low at less than 1%.<span class="mw-ref" id="cite_ref-WattsFaingold2009_56-0"><a href="#cite_note-WattsFaingold2009-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span><span class="mw-ref" id="cite_ref-GerallMoltz2013_48-3"><a href="#cite_note-GerallMoltz2013-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span> In one survey of over 9,000<span>&nbsp;</span>patients taking cimetidine, gynecomastia was the most frequent endocrine-related complaint but was reported in only 0.2% of patients.<span class="mw-ref" id="cite_ref-GerallMoltz2013_48-4"><a href="#cite_note-GerallMoltz2013-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span> At high doses however, such as those used to treat Zollinger–Ellison syndrome, there may be a higher incidence of gynecomastia with cimetidine.<span class="mw-ref" id="cite_ref-WattsFaingold2009_56-1"><a href="#cite_note-WattsFaingold2009-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span> In one small study, a 20% incidence of gynecomastia was observed in 25<span>&nbsp;</span>male patients with duodenal ulcers who were treated with 1,600<span>&nbsp;</span>mg/day cimetidine.<span class="mw-ref" id="cite_ref-pmid22862307_55-1"><a href="#cite_note-pmid22862307-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span> The symptoms appeared after 4<span>&nbsp;</span>months of treatment and regressed within a month following discontinuation of cimetidine.<span class="mw-ref" id="cite_ref-pmid22862307_55-2"><a href="#cite_note-pmid22862307-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span> In another small study, cimetidine was reported to have induced breast changes and erectile dysfunction in 60% of 22<span>&nbsp;</span>men treated with it.<span class="mw-ref" id="cite_ref-pmid22862307_55-3"><a href="#cite_note-pmid22862307-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span> These adverse effects completely resolved in all cases when the men were switched from cimetidine to <a href="Ranitidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ranitidine" title="Ranitidine">ranitidine</a>.<span class="mw-ref" id="cite_ref-pmid22862307_55-4"><a href="#cite_note-pmid22862307-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span> A study of the United Kingdom General Practice Research Database, which contains over 80,000<span>&nbsp;</span>men, found that the relative risk of gynecomastia in cimetidine users was 7.2 relative to non-users.<span class="mw-ref" id="cite_ref-pmid22862307_55-5"><a href="#cite_note-pmid22862307-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span> People taking a dosage of cimetidine of greater than or equal to 1,000<span>&nbsp;</span>mg showed more than 40<span>&nbsp;</span>times the risk of gynecomastia than non-users.<span class="mw-ref" id="cite_ref-pmid22862307_55-6"><a href="#cite_note-pmid22862307-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span> The risk was highest during the period of time of 7 to 12<span>&nbsp;</span>months after starting cimetidine.<span class="mw-ref" id="cite_ref-pmid22862307_55-7"><a href="#cite_note-pmid22862307-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span> The gynecomastia associated with cimetidine is thought to be due to blockade of ARs in the breasts, which results in estrogen action unopposed by androgens in this tissue, although increased levels of estrogens due to inhibition of estrogen metabolism is another possible mechanism.<span class="mw-ref" id="cite_ref-pmid22862307_55-8"><a href="#cite_note-pmid22862307-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span> Cimetidine has also been associated with oligospermia (decreased sperm count) and sexual dysfunction (e.g., decreased libido, erectile dysfunction) in men in some research, which are hormonally related similarly.<span class="mw-ref" id="cite_ref-PlessisAgarwal2014_49-2"><a href="#cite_note-PlessisAgarwal2014-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span><span class="mw-ref" id="cite_ref-GerallMoltz2013_48-5"><a href="#cite_note-GerallMoltz2013-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span><span class="mw-ref" id="cite_ref-pmid22862307_55-9"><a href="#cite_note-pmid22862307-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span></p>

<p>In accordance with the very weak nature of its AR antagonistic activity, cimetidine has shown minimal effectiveness in the treatment of androgen-dependent conditions such as acne, hirsutism (excessive hair growth), and hyperandrogenism (high androgen levels) in women.<span class="mw-ref" id="cite_ref-AltchekDeligdisch2003_57-0"><a href="#cite_note-AltchekDeligdisch2003-57" style="counter-reset: mw-Ref 57;"><span class="mw-reflink-text">[57]</span></a></span><span class="mw-ref" id="cite_ref-PreglerDeCherney2002_58-0"><a href="#cite_note-PreglerDeCherney2002-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span><span class="mw-ref" id="cite_ref-WattsFaingold2009_56-2"><a href="#cite_note-WattsFaingold2009-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span><span class="mw-ref" id="cite_ref-pmid20082945_59-0"><a href="#cite_note-pmid20082945-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span> As such, its use for such indications is not recommended.<span class="mw-ref" id="cite_ref-PreglerDeCherney2002_58-1"><a href="#cite_note-PreglerDeCherney2002-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span><span class="mw-ref" id="cite_ref-pmid20082945_59-1"><a href="#cite_note-pmid20082945-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span></p>

<span>
</span><table class="wikitable sortable mw-collapsible mw-collapsed" style="text-align:left; margin-left:auto; margin-right:auto; border:none;">
<caption class="nowrap"> Affinities of selected ligands at the androgen receptor</caption>
<tbody><tr>
<th>Compound</th><th><abbr>AR</abbr> <abbr>RBA</abbr> (%)</th><th><abbr>AR</abbr> K<sub>i</sub> (nM)</th></tr>
<tr>
<td><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Metribolone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Metribolone'" tppabs="https://ptable.com/wiki/compounds/A/Metribolone" title="Metribolone">Metribolone</a></td><td>100</td><td>1.18</td></tr>
<tr>
<td>Dihydrotestosterone</td><td>136</td><td>0.87</td></tr>
<tr>
<td>Testosterone</td><td>117</td><td>1.01</td></tr>
<tr>
<td><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a></td><td>67.0</td><td>1.76</td></tr>
<tr>
<td>Trimethyltrienolone</td><td>14.8</td><td>8.0</td></tr>
<tr>
<td>Megestrol acetate</td><td>13.6</td><td>8.7</td></tr>
<tr>
<td>Cyproterone acetate</td><td>12.5</td><td>9.5</td></tr>
<tr>
<td>Progesterone</td><td>6.6</td><td>18</td></tr>
<tr>
<td>Estradiol</td><td>4.9</td><td>24</td></tr>
<tr>
<td><a href="Androstenedione.htm" tppabs="https://ptable.com/wiki/compounds/A/Androstenedione" title="Androstenedione">Androstenedione</a></td><td>2.0</td><td>58</td></tr>
<tr>
<td>Canrenone</td><td>0.84</td><td>140</td></tr>
<tr>
<td><a href="Flutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Flutamide" title="Flutamide">Flutamide</a></td><td>0.079</td><td>1200</td></tr>
<tr>
<td>Cimetidine</td><td>0.00084</td><td>140,000</td></tr>
<tr class="sortbottom">
<td colspan="3" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Notes:</b> (1) Human skin fibroblasts used for assays. (2) Situation <i>in vivo</i> is different for flutamide and spironolactone due biotransformation. (3) Conflicting findings for spironolactone. <b>Sources:</b> See template.</td></tr>
</tbody></table>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacokinetics">Pharmacokinetics</h3></summary>
    
<p>Cimetidine is rapidly absorbed regardless of route of administration.<span class="mw-ref" id="cite_ref-AcademicPress1984_5-3"><a href="#cite_note-AcademicPress1984-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> The oral bioavailability of cimetidine is 60 to 70%.<span class="mw-ref" id="cite_ref-DowdJohnson2016_3-1"><a href="#cite_note-DowdJohnson2016-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-LeikinPaloucek1995_4-6"><a href="#cite_note-LeikinPaloucek1995-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> The onset of action of cimetidine when taken orally is 30<span>&nbsp;</span>minutes,<span class="mw-ref" id="cite_ref-VallerandSanoski2016_6-2"><a href="#cite_note-VallerandSanoski2016-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> and peak levels occur within 1 to 3<span>&nbsp;</span>hours.<span class="mw-ref" id="cite_ref-DowdJohnson2016_3-2"><a href="#cite_note-DowdJohnson2016-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> Cimetidine is widely distributed throughout all tissues.<span class="mw-ref" id="cite_ref-AcademicPress1984_5-4"><a href="#cite_note-AcademicPress1984-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> It is able to cross the blood–brain barrier and can produce effects in the central nervous system (e.g., headaches, dizziness, somnolence).<span class="mw-ref" id="cite_ref-GuptaSingh-Radcliff2013_2-2"><a href="#cite_note-GuptaSingh-Radcliff2013-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> The volume of distribution of cimetidine is 0.8<span>&nbsp;</span>L/kg in adults and 1.2 to 2.1<span>&nbsp;</span>L/kg in children.<span class="mw-ref" id="cite_ref-LeikinPaloucek1995_4-7"><a href="#cite_note-LeikinPaloucek1995-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Its plasma protein binding is 13 to 25% and is said to be without pharmacological significance.<span class="mw-ref" id="cite_ref-LeikinPaloucek1995_4-8"><a href="#cite_note-LeikinPaloucek1995-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-AcademicPress1984_5-5"><a href="#cite_note-AcademicPress1984-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> Cimetidine undergoes relatively little metabolism, with 56 to 85% excreted unchanged.<span class="mw-ref" id="cite_ref-AcademicPress1984_5-6"><a href="#cite_note-AcademicPress1984-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> It is metabolized in the liver into cimetidine sulfoxide, hydroxycimetidine, and guanyl urea cimetidine.<span class="mw-ref" id="cite_ref-LeikinPaloucek1995_4-9"><a href="#cite_note-LeikinPaloucek1995-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> The major metabolite of cimetidine is the <a href="Sulfoxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Sulfoxide" title="Sulfoxide">sulfoxide</a>, which accounts for about 30% of excreted material.<span class="mw-ref" id="cite_ref-AcademicPress1984_5-7"><a href="#cite_note-AcademicPress1984-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> Cimetidine is rapidly eliminated, with an elimination half-life of 123<span>&nbsp;</span>minutes, or about 2<span>&nbsp;</span>hours.<span class="mw-ref" id="cite_ref-AcademicPress1984_5-8"><a href="#cite_note-AcademicPress1984-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> It has been said to have a duration of action of 4 to 8<span>&nbsp;</span>hours.<span class="mw-ref" id="cite_ref-GuptaSingh-Radcliff2013_2-3"><a href="#cite_note-GuptaSingh-Radcliff2013-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> The medication is mainly eliminated in urine.<span class="mw-ref" id="cite_ref-AcademicPress1984_5-9"><a href="#cite_note-AcademicPress1984-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>Cimetidine, approved by the FDA for inhibition of gastric acid secretion, has been advocated for a number of dermatological diseases.<span class="mw-ref" id="cite_ref-60"><a href="#cite_note-60" style="counter-reset: mw-Ref 60;"><span class="mw-reflink-text">[60]</span></a></span> Cimetidine was the prototypical histamine H<sub>2</sub> receptor antagonist from which the later members of the class were developed. Cimetidine was the culmination of a project at Smith, Kline and French (SK&amp;F) Laboratories in Welwyn Garden City (now part of GlaxoSmithKline) by James W. Black, C. Robin Ganellin, and others to develop a histamine receptor antagonist to suppress stomach acid secretion.<span class="mw-ref" id="cite_ref-ACS_Landmarks_61-0"><a href="#cite_note-ACS_Landmarks-61" style="counter-reset: mw-Ref 61;"><span class="mw-reflink-text">[61]</span></a></span> This was one of the first drugs discovered using a rational drug design approach. Sir James W. Black shared the 1988 Nobel Prize in Physiology or Medicine for the discovery of <a href="Propranolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Propranolol" title="Propranolol">propranolol</a> and also is credited for the discovery of cimetidine.</p>

<p>At the time (1964), <a href="Histamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Histamine" title="Histamine">histamine</a> was known to stimulate the secretion of stomach acid, but also that traditional antihistamines had no effect on acid production. In the process, the SK&amp;F scientists also proved the existence of histamine H<sub>2</sub> receptors.</p>

<p>The SK&amp;F team used a rational drug-design structure starting from the structure of histamine — the only design lead, since nothing was known of the then hypothetical H<sub>2</sub> receptor. Hundreds of modified compounds were synthesized in an effort to develop a model of the receptor. The first breakthrough was <i>N<sup>α</sup></i>-guanylhistamine, a partial H<sub>2</sub> receptor antagonist. From this lead, the receptor model was further refined and eventually led to the development of burimamide, the first H<sub>2</sub> receptor antagonist. Burimamide, a specific competitive antagonist at the H<sub>2</sub> receptor, 100 times more potent than <i>N<sup>α</sup></i>-guanylhistamine, proved the existence of the H<sub>2</sub> receptor.</p>

<p>Burimamide was still insufficiently potent for oral administration, and further modification of the structure, based on modifying the pKa of the compound, led to the development of metiamide. Metiamide was an effective agent; it was associated, however, with unacceptable nephrotoxicity and agranulocytosis.<span class="mw-ref" id="cite_ref-ACS_Landmarks_61-1"><a href="#cite_note-ACS_Landmarks-61" style="counter-reset: mw-Ref 61;"><span class="mw-reflink-text">[61]</span></a></span> The toxicity was proposed to arise from the <a href="Thiourea.htm" tppabs="https://ptable.com/wiki/compounds/A/Thiourea" title="Thiourea">thiourea</a> group, and similar <a href="Guanidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Guanidine" title="Guanidine">guanidine</a> analogues were investigated until the ultimate discovery of cimetidine. The compound was synthesized in 1972 and evaluated for toxicology by 1973. It passed all trials.</p>

<p>Cimetidine was first marketed in the United Kingdom in 1976, and in the U.S. in August 1977; therefore, it took 12 years from initiation of the H<sub>2</sub> receptor antagonist program to commercialization. By 1979, Tagamet was being sold in more than 100 countries and became the top-selling prescription product in the U.S., Canada, and several other countries. In November 1997, the American Chemical Society and the Royal Society of Chemistry in the U.K. jointly recognized the work as a milestone in drug discovery by designating it an International Historic Chemical Landmark during a ceremony at SmithKline Beecham's New Frontiers Science Park research facilities in Harlow, England.<span class="mw-ref" id="cite_ref-Freemantle_62-0"><a href="#cite_note-Freemantle-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span></p>

<p>The commercial name "Tagamet" was decided upon by fusing the two words "an<b>tag</b>onist" and "ci<b>met</b>idine".<span class="mw-ref" id="cite_ref-ACS_Landmarks_61-2"><a href="#cite_note-ACS_Landmarks-61" style="counter-reset: mw-Ref 61;"><span class="mw-reflink-text">[61]</span></a></span> Subsequent to the introduction onto the U.S. drug market, two other H<sub>2</sub> receptor antagonists were approved, <a href="Ranitidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ranitidine" title="Ranitidine">ranitidine</a> (Zantac, Glaxo Labs) and <a href="Famotidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Famotidine" title="Famotidine">famotidine</a> (Pepcid, Yamanouchi, Ltd.) Cimetidine became the first drug ever to reach more than $1 billion a year in sales, thus making it the first blockbuster drug.<span class="mw-ref" id="cite_ref-63"><a href="#cite_note-63" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span></p>

<p>In a deal expected to take effect in 2012, GlaxoSmithKline sold Tagamet and 16 other brands to Prestige Brands.<span class="mw-ref" id="cite_ref-64"><a href="#cite_note-64" style="counter-reset: mw-Ref 64;"><span class="mw-reflink-text">[64]</span></a></span></p>

<p>Tagamet has now been largely replaced by the proton pump inhibitors for treating peptic ulcers, but is now available as an over-the-counter medicine for heartburn in many countries.<span class="mw-ref" id="cite_ref-Freemantle_62-1"><a href="#cite_note-Freemantle-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist columns references-column-width" style="-moz-column-width: 33em; -webkit-column-width: 33em; column-width: 33em; list-style-type: decimal;">
<ol class="mw-references references"><li id="cite_note-Elks2014-1"> <span id="mw-reference-text-cite_note-Elks2014-1" class="mw-reference-text"><cite id="CITEREFElks2014" class="citation book cs1">Elks J (14 November 2014). <a href="javascript:if(confirm('https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA275  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA275'" tppabs="https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA275" class="external text external"><i>The Dictionary of Drugs: Chemical Data: Chemical Data, Bibliographies</i></a>. Springer. pp.<span>&nbsp;</span>275–. ISBN<span>&nbsp;</span><bdi>978-1-4757-2085-3</bdi>.</cite></span></li><li id="cite_note-GuptaSingh-Radcliff2013-2"> <span id="mw-reference-text-cite_note-GuptaSingh-Radcliff2013-2" class="mw-reference-text"><cite id="CITEREFAnita_GuptaNina_Singh-Radcliff2013" class="citation book cs1">Anita Gupta; Nina Singh-Radcliff (12 March 2013). <a href="javascript:if(confirm('https://books.google.com/books?id=a85oAgAAQBAJ&pg=PT177  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=a85oAgAAQBAJ&pg=PT177'" tppabs="https://books.google.com/books?id=a85oAgAAQBAJ&pg=PT177" class="external text external"><i>Pharmacology in Anesthesia Practice</i></a>. Oxford University Press. pp.<span>&nbsp;</span>177–. ISBN<span>&nbsp;</span><bdi>978-0-19-934399-7</bdi>.</cite></span></li><li id="cite_note-DowdJohnson2016-3"> <span id="mw-reference-text-cite_note-DowdJohnson2016-3" class="mw-reference-text"><cite id="CITEREFFrank_J._DowdBart_JohnsonAngelo_Mariotti2016" class="citation book cs1">Frank J. Dowd; Bart Johnson; Angelo Mariotti (3 September 2016). <a href="javascript:if(confirm('https://books.google.com/books?id=6xT7DAAAQBAJ&pg=PA406  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=6xT7DAAAQBAJ&pg=PA406'" tppabs="https://books.google.com/books?id=6xT7DAAAQBAJ&pg=PA406" class="external text external"><i>Pharmacology and Therapeutics for Dentistry - E-Book</i></a>. Elsevier Health Sciences. pp.<span>&nbsp;</span>406–. ISBN<span>&nbsp;</span><bdi>978-0-323-44595-5</bdi>.</cite></span></li><li id="cite_note-LeikinPaloucek1995-4"> <span id="mw-reference-text-cite_note-LeikinPaloucek1995-4" class="mw-reference-text"><cite id="CITEREFJerrold_B._LeikinFrank_P._Paloucek1995" class="citation book cs1">Jerrold B. Leikin; Frank P. Paloucek (1995). <a href="javascript:if(confirm('https://books.google.com/books?id=JpZrAAAAMAAJ  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=JpZrAAAAMAAJ'" tppabs="https://books.google.com/books?id=JpZrAAAAMAAJ" class="external text external"><i>Poisoning &amp; Toxicology Handbook, 1995-1996</i></a>. Lexi-Comp, Incorporated. p.<span>&nbsp;</span>184. ISBN<span>&nbsp;</span><bdi>978-0-916589-08-0</bdi>.</cite></span></li><li id="cite_note-AcademicPress1984-5"> <span id="mw-reference-text-cite_note-AcademicPress1984-5" class="mw-reference-text"><cite class="citation book cs1"><a href="javascript:if(confirm('https://books.google.com/books?id=Fz6X-GmS-GgC&pg=PA176  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=Fz6X-GmS-GgC&pg=PA176'" tppabs="https://books.google.com/books?id=Fz6X-GmS-GgC&pg=PA176" class="external text external"><i>Profiles of Drug Substances, Excipients and Related Methodology</i></a>. Academic Press. 24 October 1984. pp.<span>&nbsp;</span>176–. ISBN<span>&nbsp;</span><bdi>978-0-08-086108-1</bdi>.</cite></span></li><li id="cite_note-VallerandSanoski2016-6"> <span id="mw-reference-text-cite_note-VallerandSanoski2016-6" class="mw-reference-text"><cite id="CITEREFVallerandSanoskiDeglin2016" class="citation book cs1">Vallerand AH, Sanoski CA, Deglin JH (25 May 2016). <a href="javascript:if(confirm('https://books.google.com/books?id=ORa1DAAAQBAJ&pg=PA636  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=ORa1DAAAQBAJ&pg=PA636'" tppabs="https://books.google.com/books?id=ORa1DAAAQBAJ&pg=PA636" class="external text external"><i>Davis's Drug Guide for Nurses</i></a>. F.A. Davis. pp.<span>&nbsp;</span>636–. ISBN<span>&nbsp;</span><bdi>978-0-8036-5779-3</bdi>.</cite></span></li><li id="cite_note-IndexNominum2000-7"> <span id="mw-reference-text-cite_note-IndexNominum2000-7" class="mw-reference-text"><cite class="citation book cs1"><a href="javascript:if(confirm('https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA234  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA234'" tppabs="https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA234" class="external text external"><i>Index Nominum 2000: International Drug Directory</i></a>. Taylor &amp; Francis. January 2000. pp.<span>&nbsp;</span>234–. ISBN<span>&nbsp;</span><bdi>978-3-88763-075-1</bdi>.</cite></span></li><li id="cite_note-MortonMorton1999-8"> <span id="mw-reference-text-cite_note-MortonMorton1999-8" class="mw-reference-text"><cite id="CITEREFMortonMortonHall1999" class="citation book cs1">Morton I, Morton IK, Hall JM (31 October 1999). <a href="javascript:if(confirm('https://books.google.com/books?id=mqaOMOtk61IC&pg=PA77  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=mqaOMOtk61IC&pg=PA77'" tppabs="https://books.google.com/books?id=mqaOMOtk61IC&pg=PA77" class="external text external"><i>Concise Dictionary of Pharmacological Agents: Properties and Synonyms</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>77–. ISBN<span>&nbsp;</span><bdi>978-0-7514-0499-9</bdi>.</cite></span></li><li id="cite_note-BurchumRosenthal2014-9"> <span id="mw-reference-text-cite_note-BurchumRosenthal2014-9" class="mw-reference-text"><cite id="CITEREFBurchumRosenthal2014" class="citation book cs1">Burchum J, Rosenthal L (2 December 2014). <a href="javascript:if(confirm('https://books.google.com/books?id=C7_NBQAAQBAJ&pg=PA952  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=C7_NBQAAQBAJ&pg=PA952'" tppabs="https://books.google.com/books?id=C7_NBQAAQBAJ&pg=PA952" class="external text external"><i>Lehne's Pharmacology for Nursing Care</i></a>. Elsevier Health Sciences. pp.<span>&nbsp;</span>952–. ISBN<span>&nbsp;</span><bdi>978-0-323-34026-7</bdi>.</cite></span></li><li id="cite_note-FischerGanellin2010-10"> <span id="mw-reference-text-cite_note-FischerGanellin2010-10" class="mw-reference-text"><cite id="CITEREFFischerGanellin2010" class="citation book cs1">Fischer J, Ganellin CR (24 August 2010). <a href="javascript:if(confirm('https://books.google.com/books?id=h2Kd8ci4Ln8C&pg=PA4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=h2Kd8ci4Ln8C&pg=PA4'" tppabs="https://books.google.com/books?id=h2Kd8ci4Ln8C&pg=PA4" class="external text external"><i>Analogue-based Drug Discovery II</i></a>. John Wiley &amp; Sons. p.<span>&nbsp;</span>4. ISBN<span>&nbsp;</span><bdi>978-3-527-63212-1</bdi>.</cite></span></li><li id="cite_note-11"> <span id="mw-reference-text-cite_note-11" class="mw-reference-text"><cite id="CITEREFFischerGanellin2006" class="citation book cs1">Fischer, Janos; Ganellin, C. Robin (2006). <a href="javascript:if(confirm('https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA444  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA444'" tppabs="https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA444" class="external text external"><i>Analogue-based Drug Discovery</i></a>. John Wiley &amp; Sons. p.<span>&nbsp;</span>444. ISBN<span>&nbsp;</span><bdi>9783527607495</bdi>.</cite></span></li><li id="cite_note-12"> <span id="mw-reference-text-cite_note-12" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017939  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017939'" tppabs="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017939" class="external text external">"Drugs@FDA: FDA Approved Drug Products"</a>.</cite></span></li><li id="cite_note-13"> <span id="mw-reference-text-cite_note-13" class="mw-reference-text"><cite id="CITEREFFitWilliams2007" class="citation journal cs1">Fit KE, Williams PC (July 2007). "Use of histamine2-antagonists for the treatment of verruca vulgaris". <i>The Annals of Pharmacotherapy</i>. <b>41</b> (7): 1222–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1345%2Faph.1H616  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1345%2Faph.1H616'" tppabs="https://doi.org/10.1345%2Faph.1H616" class="external text external">10.1345/aph.1H616</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17535844  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17535844'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17535844" class="external text external">17535844</a>.</cite></span></li><li id="cite_note-14"> <span id="mw-reference-text-cite_note-14" class="mw-reference-text"><cite id="CITEREFGlassSolomon1996" class="citation journal cs1">Glass AT, Solomon BA (June 1996). "Cimetidine therapy for recalcitrant warts in adults". <i>Archives of Dermatology</i>. <b>132</b> (6): 680–2. doi:<a href="javascript:if(confirm('https://doi.org/10.1001%2Farchderm.1996.03890300108014  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Farchderm.1996.03890300108014'" tppabs="https://doi.org/10.1001%2Farchderm.1996.03890300108014" class="external text external">10.1001/archderm.1996.03890300108014</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8651718  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8651718'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8651718" class="external text external">8651718</a>.</cite></span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text"><cite id="CITEREFKarabulutSahinEkşioglu1997" class="citation journal cs1">Karabulut AA, Sahin S, Ekşioglu M (April 1997). "Is cimetidine effective for nongenital warts: a double-blind, placebo-controlled study". <i>Archives of Dermatology</i>. <b>133</b> (4): 533–4. doi:<a href="javascript:if(confirm('https://doi.org/10.1001%2Farchderm.133.4.533  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Farchderm.133.4.533'" tppabs="https://doi.org/10.1001%2Farchderm.133.4.533" class="external text external">10.1001/archderm.133.4.533</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9126017  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9126017'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9126017" class="external text external">9126017</a>.</cite></span></li><li id="cite_note-16"> <span id="mw-reference-text-cite_note-16" class="mw-reference-text"><cite id="CITEREFDevaJameson2012" class="citation journal cs1">Deva S, Jameson M (15 August 2012). "Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer". <i>The Cochrane Database of Systematic Reviews</i>. <b>8</b> (8): CD007814. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD007814.pub2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD007814.pub2'" tppabs="https://doi.org/10.1002%2F14651858.CD007814.pub2" class="external text external">10.1002/14651858.CD007814.pub2</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22895966  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22895966'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22895966" class="external text external">22895966</a>.</cite></span></li><li id="cite_note-17"> <span id="mw-reference-text-cite_note-17" class="mw-reference-text"><cite id="CITEREFWhatleyBadmintonPagonAdam2013" class="citation book cs1">Whatley, SD; Badminton, MN; Pagon, RA; Adam, MP; Ardinger, HH; Wallace, SE; Amemiya, A; Bean, LJH; Bird, TD; Ledbetter, N; Mefford, HC; Smith, RJH; Stephens, K (2013). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/books/NBK1193/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/books/NBK1193/'" tppabs="https://www.ncbi.nlm.nih.gov/books/NBK1193/" class="external text external"><i>Acute Intermittent Porphyria</i></a>. University of Washington, Seattle. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20301372  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20301372'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20301372" class="external text external">20301372</a>.</cite></span></li><li id="cite_note-18"> <span id="mw-reference-text-cite_note-18" class="mw-reference-text"><cite id="CITEREFSchug,_SA;_Palmer,_GM;_Scott,_DA;_Halliwell,_R;_Trinca,_J;_APM:SE_Working_Group_of_the_Australian_and_New_Zealand_College_of_Anaesthetists_and_Faculty_of_Pain_Medicine2015" class="citation book cs1">Schug, SA; Palmer, GM; Scott, DA; Halliwell, R; Trinca, J; APM:SE Working Group of the Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine (2015). <a href="javascript:if(confirm('https://web.archive.org/web/20190731120330/http://fpm.anzca.edu.au/documents/apmse4_2015_final  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20190731120330/http://fpm.anzca.edu.au/documents/apmse4_2015_final'" tppabs="https://web.archive.org/web/20190731120330/http://fpm.anzca.edu.au/documents/apmse4_2015_final" class="external text external"><i>Acute Pain Management: Scientific Evidence</i></a> (4th ed.). Melbourne, Australia: Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine. p.<span>&nbsp;</span>316. ISBN<span>&nbsp;</span><bdi>978-0-9873236-6-8</bdi>. Archived from <a href="javascript:if(confirm('http://fpm.anzca.edu.au/documents/apmse4_2015_final  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://fpm.anzca.edu.au/documents/apmse4_2015_final'" tppabs="http://fpm.anzca.edu.au/documents/apmse4_2015_final" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 31 July 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">7 September</span> 2017</span>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-ped-rheum-19"> <span id="mw-reference-text-cite_note-ped-rheum-19" class="mw-reference-text"><cite id="CITEREFVanoniTheodoropoulouHofer2016" class="citation journal cs1">Vanoni, Federica; Theodoropoulou, Katerina; Hofer, Michaël (27 June 2016). <a href="javascript:if(confirm('https://ped-rheum.biomedcentral.com/articles/10.1186/s12969-016-0101-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ped-rheum.biomedcentral.com/articles/10.1186/s12969-016-0101-9'" tppabs="https://ped-rheum.biomedcentral.com/articles/10.1186/s12969-016-0101-9" class="external text external">"PFAPA syndrome: a review on treatment and outcome"</a>. <i>Pediatric Rheumatology</i>. doi:<a href="javascript:if(confirm('https://doi.org/10.1186%2Fs12969-016-0101-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1186%2Fs12969-016-0101-9'" tppabs="https://doi.org/10.1186%2Fs12969-016-0101-9" class="external text external">10.1186/s12969-016-0101-9</a><span class="reference-accessdate">. Retrieved <span class="nowrap">3 July</span> 2020</span>.</cite></span></li><li id="cite_note-RitterLewis2008-20"> <span id="mw-reference-text-cite_note-RitterLewis2008-20" class="mw-reference-text"><cite id="CITEREFRitterLewisMantFerro2008" class="citation book cs1">Ritter J, Lewis L, Mant T, Ferro A (25 April 2008). <a href="javascript:if(confirm('https://books.google.com/books?id=TD59BgAAQBAJ&pg=PA250  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=TD59BgAAQBAJ&pg=PA250'" tppabs="https://books.google.com/books?id=TD59BgAAQBAJ&pg=PA250" class="external text external"><i>A Textbook of Clinical Pharmacology and Therapeutics</i></a> (5 ed.). CRC Press. pp.<span>&nbsp;</span>250–. ISBN<span>&nbsp;</span><bdi>978-1-4441-1300-6</bdi>.</cite></span></li><li id="cite_note-21"> <span id="mw-reference-text-cite_note-21" class="mw-reference-text"><cite id="CITEREFSawyerConnerScalley1981" class="citation journal cs1">Sawyer D, Conner CS, Scalley R (February 1981). "Cimetidine: adverse reactions and acute toxicity". <i>American Journal of Hospital Pharmacy</i>. <b>38</b> (2): 188–97. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7011006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7011006'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7011006" class="external text external">7011006</a>.</cite></span></li><li id="cite_note-22"> <span id="mw-reference-text-cite_note-22" class="mw-reference-text"><cite id="CITEREFSabesin1993" class="citation journal cs1">Sabesin SM (1993). "Safety issues relating to long-term treatment with histamine H2-receptor antagonists". <i>Alimentary Pharmacology &amp; Therapeutics</i>. 7 Suppl 2: 35–40. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1365-2036.1993.tb00597.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1365-2036.1993.tb00597.x'" tppabs="https://doi.org/10.1111%2Fj.1365-2036.1993.tb00597.x" class="external text external">10.1111/j.1365-2036.1993.tb00597.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8103374  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8103374'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8103374" class="external text external">8103374</a>.</cite></span></li><li id="cite_note-Kelly2009-23"> <span id="mw-reference-text-cite_note-Kelly2009-23" class="mw-reference-text"><cite id="CITEREFKelly2009" class="citation book cs1">Kelly D (26 January 2009). <a href="javascript:if(confirm('https://books.google.com/books?id=z7nO3OrNXckC&pg=PA224  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=z7nO3OrNXckC&pg=PA224'" tppabs="https://books.google.com/books?id=z7nO3OrNXckC&pg=PA224" class="external text external"><i>Diseases of the Liver and Biliary System in Children</i></a>. John Wiley &amp; Sons. pp.<span>&nbsp;</span>224–. ISBN<span>&nbsp;</span><bdi>978-1-4443-0054-3</bdi>.</cite></span></li><li id="cite_note-Dart2004-24"> <span id="mw-reference-text-cite_note-Dart2004-24" class="mw-reference-text"><cite id="CITEREFDart2004" class="citation book cs1">Dart RC (2004). <a href="javascript:if(confirm('https://books.google.com/books?id=BfdighlyGiwC&pg=PA402  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=BfdighlyGiwC&pg=PA402'" tppabs="https://books.google.com/books?id=BfdighlyGiwC&pg=PA402" class="external text external"><i>Medical Toxicology</i></a>. Lippincott Williams &amp; Wilkins. pp.<span>&nbsp;</span>402–. ISBN<span>&nbsp;</span><bdi>978-0-7817-2845-4</bdi>.</cite></span></li><li id="cite_note-25"> <span id="mw-reference-text-cite_note-25" class="mw-reference-text"><cite id="CITEREFFurst1996" class="citation journal cs1">Furst DE (June 1996). "Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases". <i>Lupus</i>. 5 Suppl 1: S11–5. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F096120339600500104  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F096120339600500104'" tppabs="https://doi.org/10.1177%2F096120339600500104" class="external text external">10.1177/096120339600500104</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8803904  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8803904'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8803904" class="external text external">8803904</a>.</cite></span></li><li id="cite_note-26"> <span id="mw-reference-text-cite_note-26" class="mw-reference-text">See complete drug interactions for Zomig (zolmitriptan succinate used for migraine relief) in package insert: <cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20150218190357/http://www1.astrazeneca-us.com/pi/Zomig.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20150218190357/http://www1.astrazeneca-us.com/pi/Zomig.pdf'" tppabs="https://web.archive.org/web/20150218190357/http://www1.astrazeneca-us.com/pi/Zomig.pdf" class="external text external">"Highlights of Zomig Prescribing Information"</a> <span class="cs1-format">(PDF)</span>. AstraZeneca. Archived from <a href="javascript:if(confirm('http://www1.astrazeneca-us.com/pi/Zomig.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www1.astrazeneca-us.com/pi/Zomig.pdf'" tppabs="http://www1.astrazeneca-us.com/pi/Zomig.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 2015-02-18<span class="reference-accessdate">. Retrieved <span class="nowrap">2010-01-28</span></span>.</cite></span></li><li id="cite_note-27"> <span id="mw-reference-text-cite_note-27" class="mw-reference-text"><cite id="CITEREFUrakamiKimuraOkudaMasuda2005" class="citation journal cs1">Urakami Y, Kimura N, Okuda M, Masuda S, Katsura T, Inui K (June 2005). "Transcellular transport of creatinine in renal tubular epithelial cell line LLC-PK1". <i>Drug Metabolism and Pharmacokinetics</i>. <b>20</b> (3): 200–5. doi:<a href="javascript:if(confirm('https://doi.org/10.2133%2Fdmpk.20.200  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2133%2Fdmpk.20.200'" tppabs="https://doi.org/10.2133%2Fdmpk.20.200" class="external text external">10.2133/dmpk.20.200</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15988122  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15988122'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15988122" class="external text external">15988122</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:13857940  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:13857940'" tppabs="https://api.semanticscholar.org/CorpusID:13857940" class="external text external">13857940</a>.</cite></span></li><li id="cite_note-Rodrigues2008-28"> <span id="mw-reference-text-cite_note-Rodrigues2008-28" class="mw-reference-text"><cite id="CITEREFRodrigues2008" class="citation book cs1">Rodrigues AD (8 February 2008). <a href="javascript:if(confirm('https://books.google.com/books?id=rmCGQ8qAv8AC&pg=PA294  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=rmCGQ8qAv8AC&pg=PA294'" tppabs="https://books.google.com/books?id=rmCGQ8qAv8AC&pg=PA294" class="external text external"><i>Drug-Drug Interactions, Second Edition</i></a>. CRC Press. pp.<span>&nbsp;</span>277, 294. ISBN<span>&nbsp;</span><bdi>978-0-8493-7594-1</bdi>.</cite></span></li><li id="cite_note-Zhou2016-29"> <span id="mw-reference-text-cite_note-Zhou2016-29" class="mw-reference-text"><cite id="CITEREFShufeng_Zhou2016" class="citation book cs1">Shufeng Zhou (6 April 2016). <a href="javascript:if(confirm('https://books.google.com/books?id=UJqmCwAAQBAJ&pg=PA299  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=UJqmCwAAQBAJ&pg=PA299'" tppabs="https://books.google.com/books?id=UJqmCwAAQBAJ&pg=PA299" class="external text external"><i>Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism</i></a>. CRC Press. pp.<span>&nbsp;</span>299–. ISBN<span>&nbsp;</span><bdi>978-1-4665-9788-4</bdi>.</cite></span></li><li id="cite_note-RosenfeldLoose2007-30"> <span id="mw-reference-text-cite_note-RosenfeldLoose2007-30" class="mw-reference-text"><cite id="CITEREFRosenfeldLoose2007" class="citation book cs1">Rosenfeld GC, Loose DS (2007). <a href="javascript:if(confirm('https://books.google.com/books?id=fm8kmMDjdiAC&pg=PA202  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=fm8kmMDjdiAC&pg=PA202'" tppabs="https://books.google.com/books?id=fm8kmMDjdiAC&pg=PA202" class="external text external"><i>Pharmacology</i></a>. Lippincott Williams &amp; Wilkins. pp.<span>&nbsp;</span>202–. ISBN<span>&nbsp;</span><bdi>978-0-7817-8074-2</bdi>.</cite></span></li><li id="cite_note-FullerSajatovic2005-31"> <span id="mw-reference-text-cite_note-FullerSajatovic2005-31" class="mw-reference-text"><cite id="CITEREFFullerSajatovic2005" class="citation book cs1">Fuller MA, Sajatovic M (2005). <a href="javascript:if(confirm('https://books.google.com/books?id=LzBtAAAAMAAJ  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=LzBtAAAAMAAJ'" tppabs="https://books.google.com/books?id=LzBtAAAAMAAJ" class="external text external"><i>Drug Information Handbook for Psychiatry</i></a>. Lexi-Comp. p.<span>&nbsp;</span>285. ISBN<span>&nbsp;</span><bdi>9781591951148</bdi>.</cite></span></li><li id="cite_note-CameronFeuer2012-32"> <span id="mw-reference-text-cite_note-CameronFeuer2012-32" class="mw-reference-text"><cite id="CITEREFCameronFeuerde_la_Iglesias2012" class="citation book cs1">Cameron R, Feuer G, de la Iglesias F (6 December 2012). <a href="javascript:if(confirm('https://books.google.com/books?id=xZf-CAAAQBAJ&pg=PA140  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=xZf-CAAAQBAJ&pg=PA140'" tppabs="https://books.google.com/books?id=xZf-CAAAQBAJ&pg=PA140" class="external text external"><i>Drug-Induced Hepatotoxicity</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>140–. ISBN<span>&nbsp;</span><bdi>978-3-642-61013-4</bdi>.</cite></span></li><li id="cite_note-pmid6317740-33"> <span id="mw-reference-text-cite_note-pmid6317740-33" class="mw-reference-text"><cite id="CITEREFRichards1983" class="citation journal cs1">Richards DA (1983). "Comparative pharmacodynamics and pharmacokinetics of cimetidine and ranitidine". <i>Journal of Clinical Gastroenterology</i>. 5 Suppl 1: 81–90. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00004836-198312001-00008  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00004836-198312001-00008'" tppabs="https://doi.org/10.1097%2F00004836-198312001-00008" class="external text external">10.1097/00004836-198312001-00008</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/6317740  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/6317740'" tppabs="https://pubmed.ncbi.nlm.nih.gov/6317740" class="external text external">6317740</a>.</cite></span></li><li id="cite_note-Osborne2013-34"> <span id="mw-reference-text-cite_note-Osborne2013-34" class="mw-reference-text"><cite id="CITEREFNeville_N._Osborne2013" class="citation book cs1">Neville N. Osborne (22 October 2013). <a href="javascript:if(confirm('https://books.google.com/books?id=ldnWAgAAQBAJ&pg=PA297  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=ldnWAgAAQBAJ&pg=PA297'" tppabs="https://books.google.com/books?id=ldnWAgAAQBAJ&pg=PA297" class="external text external"><i>Selected Topics from Neurochemistry</i></a>. Elsevier Science. pp.<span>&nbsp;</span>297–. ISBN<span>&nbsp;</span><bdi>978-1-4832-8635-8</bdi>.</cite></span></li><li id="cite_note-LemkeWilliams2008-35"> <span id="mw-reference-text-cite_note-LemkeWilliams2008-35" class="mw-reference-text"><cite id="CITEREFLemkeWilliams2008" class="citation book cs1">Lemke TL, Williams DA (2008). <a href="javascript:if(confirm('https://books.google.com/books?id=R0W1ErpsQpkC&pg=PA273  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=R0W1ErpsQpkC&pg=PA273'" tppabs="https://books.google.com/books?id=R0W1ErpsQpkC&pg=PA273" class="external text external"><i>Foye's Principles of Medicinal Chemistry</i></a>. Lippincott Williams &amp; Wilkins. pp.<span>&nbsp;</span>273–. ISBN<span>&nbsp;</span><bdi>978-0-7817-6879-5</bdi>.</cite></span></li><li id="cite_note-KarallieddeClarke2010-36"> <span id="mw-reference-text-cite_note-KarallieddeClarke2010-36" class="mw-reference-text"><cite id="CITEREFKarallieddeClarkeCollignonKaralliedde2010" class="citation book cs1">Karalliedde LD, Clarke SF, Collignon U, Karalliedde J (29 January 2010). <a href="javascript:if(confirm('https://books.google.com/books?id=B2YwH371uzYC&pg=PA633  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=B2YwH371uzYC&pg=PA633'" tppabs="https://books.google.com/books?id=B2YwH371uzYC&pg=PA633" class="external text external"><i>Adverse Drug Interactions: A Handbook for Prescribers</i></a>. CRC Press. pp.<span>&nbsp;</span>633–. ISBN<span>&nbsp;</span><bdi>978-0-340-92769-4</bdi>.</cite></span></li><li id="cite_note-PriskornLarsen1997-37"> <span id="mw-reference-text-cite_note-PriskornLarsen1997-37" class="mw-reference-text"><cite id="CITEREFPriskornLarsenSegonzacMoulin1997" class="citation journal cs1">Priskorn M, Larsen F, Segonzac A, Moulin M (1997). "Pharmacokinetic interaction study of citalopram and cimetidine in healthy subjects". <i>European Journal of Clinical Pharmacology</i>. <b>52</b> (3): 241–2. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs002280050282  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs002280050282'" tppabs="https://doi.org/10.1007%2Fs002280050282" class="external text external">10.1007/s002280050282</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9218934  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9218934'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9218934" class="external text external">9218934</a>.</cite></span></li><li id="cite_note-MartinezAlbet1999-38"> <span id="mw-reference-text-cite_note-MartinezAlbet1999-38" class="mw-reference-text"><cite id="CITEREFMartínezAlbetAgúndezHerrero1999" class="citation journal cs1">Martínez C, Albet C, Agúndez JA, Herrero E, Carrillo JA, Márquez M, Benítez J, Ortiz JA (April 1999). "Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2-receptor antagonists". <i>Clinical Pharmacology and Therapeutics</i>. <b>65</b> (4): 369–76. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0009-9236%2899%2970129-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0009-9236%2899%2970129-3'" tppabs="https://doi.org/10.1016%2FS0009-9236%2899%2970129-3" class="external text external">10.1016/S0009-9236(99)70129-3</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10223772  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10223772'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10223772" class="external text external">10223772</a>.</cite></span></li><li id="cite_note-Delafuente2003-39"> <span id="mw-reference-text-cite_note-Delafuente2003-39" class="mw-reference-text"><cite id="CITEREFDelafuente2003" class="citation journal cs1">Delafuente JC (November 2003). "Understanding and preventing drug interactions in elderly patients". <i>Critical Reviews in Oncology/Hematology</i>. <b>48</b> (2): 133–43. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.critrevonc.2003.04.004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.critrevonc.2003.04.004'" tppabs="https://doi.org/10.1016%2Fj.critrevonc.2003.04.004" class="external text external">10.1016/j.critrevonc.2003.04.004</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14607376  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14607376'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14607376" class="external text external">14607376</a>.</cite></span></li><li id="cite_note-Cairns2012-40"> <span id="mw-reference-text-cite_note-Cairns2012-40" class="mw-reference-text"><cite id="CITEREFCairns2012" class="citation book cs1">Cairns D (2012). <a href="javascript:if(confirm('https://books.google.com/books?id=gNliFkwHYgEC&pg=PA110  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=gNliFkwHYgEC&pg=PA110'" tppabs="https://books.google.com/books?id=gNliFkwHYgEC&pg=PA110" class="external text external"><i>Essentials of Pharmaceutical Chemistry</i></a>. Pharmaceutical Press. pp.<span>&nbsp;</span>110–. ISBN<span>&nbsp;</span><bdi>978-0-85369-979-8</bdi>. <q>Drugs interacting in this way with CYP450 include the histamine H2-receptor antagonist cimetidine, [...] Reversible inhibitors, such as cimetidine, which interact with the complexed iron at the active site of the enzyme to inhibit oxidation of other drugs. The inhibition occurs before any oxidation of the inhibitor occurs and is reversible once the inhibitor is removed.</q></cite></span></li><li id="cite_note-pmid9630736-41"> <span id="mw-reference-text-cite_note-pmid9630736-41" class="mw-reference-text"><cite id="CITEREFLiska1998" class="citation journal cs1">Liska DJ (June 1998). "The detoxification enzyme systems". <i>Alternative Medicine Review</i>. <b>3</b> (3): 187–98. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9630736  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9630736'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9630736" class="external text external">9630736</a>. <q>Cimetidine is an example of a compound that can bind directly to the heme iron of the cytochrome P450 reactive site to inhibit all cytochrome-dependent Phase I enzyme activities.13</q></cite></span></li><li id="cite_note-Becker2001-42"> <span id="mw-reference-text-cite_note-Becker2001-42" class="mw-reference-text"><cite id="CITEREFBecker2001" class="citation book cs1">Becker KL (2001). <a href="javascript:if(confirm('https://books.google.com/books?id=FVfzRvaucq8C&pg=PA1196  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=FVfzRvaucq8C&pg=PA1196'" tppabs="https://books.google.com/books?id=FVfzRvaucq8C&pg=PA1196" class="external text external"><i>Principles and Practice of Endocrinology and Metabolism</i></a>. Lippincott Williams &amp; Wilkins. pp.<span>&nbsp;</span>1196–. ISBN<span>&nbsp;</span><bdi>978-0-7817-1750-2</bdi>.</cite></span></li><li id="cite_note-pmid6150641-43"> <span id="mw-reference-text-cite_note-pmid6150641-43" class="mw-reference-text"><cite id="CITEREFJensenCollenMcArthurHoward1984" class="citation journal cs1">Jensen RT, Collen MJ, McArthur KE, Howard JM, Maton PN, Cherner JA, Gardner JD (November 1984). "Comparison of the effectiveness of ranitidine and cimetidine in inhibiting acid secretion in patients with gastric hypersecretory states". <i>The American Journal of Medicine</i>. <b>77</b> (5B): 90–105. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/6150641  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/6150641'" tppabs="https://pubmed.ncbi.nlm.nih.gov/6150641" class="external text external">6150641</a>.</cite></span></li><li id="cite_note-pmid3921876-44"> <span id="mw-reference-text-cite_note-pmid3921876-44" class="mw-reference-text"><cite id="CITEREFBiagiMilani1985" class="citation journal cs1">Biagi P, Milani G (March 1985). "[Dysfunction of the hypothalamo-hypophyseal-gonadal axis induced by histamine H2 antagonists. Review of the literature and personal observations]". <i>Minerva Medica</i> (in Italian). <b>76</b> (12): 579–86. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/3921876  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/3921876'" tppabs="https://pubmed.ncbi.nlm.nih.gov/3921876" class="external text external">3921876</a>.</cite></span></li><li id="cite_note-pmid428705-45"> <span id="mw-reference-text-cite_note-pmid428705-45" class="mw-reference-text"><cite id="CITEREFWintersBanksLoriaux1979" class="citation journal cs1">Winters SJ, Banks JL, Loriaux DL (March 1979). <a href="javascript:if(confirm('https://doi.org/10.1016/S0016-5085(79)80217-6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016/S0016-5085(79)80217-6'" tppabs="https://doi.org/10.1016/S0016-5085(79)80217-6" class="external text external">"Cimetidine is an antiandrogen in the rat"</a>. <i>Gastroenterology</i>. <b>76</b> (3): 504–8. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1016%2FS0016-5085%2879%2980217-6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0016-5085%2879%2980217-6'" tppabs="https://doi.org/10.1016%2FS0016-5085%2879%2980217-6" class="external text external">10.1016/S0016-5085(79)80217-6</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/428705  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/428705'" tppabs="https://pubmed.ncbi.nlm.nih.gov/428705" class="external text external">428705</a>.</cite></span></li><li id="cite_note-pmid6123322-46"> <span id="mw-reference-text-cite_note-pmid6123322-46" class="mw-reference-text"><cite id="CITEREFSivelleUnderwoodJelly1982" class="citation journal cs1">Sivelle PC, Underwood AH, Jelly JA (March 1982). "The effects of histamine H2 receptor antagonists on androgen action in vivo and dihydrotestosterone binding to the rat prostate androgen receptor in vitro". <i>Biochemical Pharmacology</i>. <b>31</b> (5): 677–84. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0006-2952%2882%2990449-X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0006-2952%2882%2990449-X'" tppabs="https://doi.org/10.1016%2F0006-2952%2882%2990449-X" class="external text external">10.1016/0006-2952(82)90449-X</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/6123322  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/6123322'" tppabs="https://pubmed.ncbi.nlm.nih.gov/6123322" class="external text external">6123322</a>.</cite></span></li><li id="cite_note-pmid6725525_b-47"> <span id="mw-reference-text-cite_note-pmid6725525_b-47" class="mw-reference-text"><cite id="CITEREFEilEdelson1984" class="citation journal cs1">Eil C, Edelson SK (July 1984). "The use of human skin fibroblasts to obtain potency estimates of drug binding to androgen receptors". <i>J. Clin. Endocrinol. Metab</i>. <b>59</b> (1): 51–5. doi:<a href="javascript:if(confirm('https://doi.org/10.1210%2Fjcem-59-1-51  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1210%2Fjcem-59-1-51'" tppabs="https://doi.org/10.1210%2Fjcem-59-1-51" class="external text external">10.1210/jcem-59-1-51</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/6725525  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/6725525'" tppabs="https://pubmed.ncbi.nlm.nih.gov/6725525" class="external text external">6725525</a>.</cite></span></li><li id="cite_note-GerallMoltz2013-48"> <span id="mw-reference-text-cite_note-GerallMoltz2013-48" class="mw-reference-text"><cite id="CITEREFArnold_A._GerallHoward_MoltzIngeborg_L._Ward2013" class="citation book cs1">Arnold A. Gerall; Howard Moltz; Ingeborg L. Ward (11 November 2013). <a href="javascript:if(confirm('https://books.google.com/books?id=4nb1BwAAQBAJ&pg=PA207  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=4nb1BwAAQBAJ&pg=PA207'" tppabs="https://books.google.com/books?id=4nb1BwAAQBAJ&pg=PA207" class="external text external"><i>Sexual Differentiation</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>207–. ISBN<span>&nbsp;</span><bdi>978-1-4899-2453-7</bdi>. <q>In high concentrations cimetidine acts as a weak antiandrogen by competitively binding to cytosol androgen receptors, as has been demonstrated in rat ventral prostate (Foldesy, Vanderhoof, &amp; Hahn, 1985; Sivelle, Underwood, &amp; Jelly, 1982) and mouse kidney tissue (Funder &amp; Mercer, 1979). In vivo, cimetidine, in high dose levels, causes reductions in prostate and seminal vesicle weights in male rats (Foldesy et al., 1985; Leslie &amp; Walker, 1977; Sivelle et al., 1982). After 6 weeks of daily cimetidine administration to male rats, reduced weights of accessory sexual organs were accompanied by elevated gonadotropin levels (Baba, Paul, Pollow, Janetschek, &amp; Jacobi, 1981). At therapeutic levels in men, cimetidine either has no effect on plasma T levels (Spona et al., 1987; Stubbs et al., 1983) or causes small increases in T (Peden, Boyd, Browning, Saunders, &amp; Wormsley, 1981; Van Thiel, Gavaler, Smith, &amp; Paul, 1979; Wang, Lai, Lam, &amp; Yeung, 1982). The increases in T have been attributed to cimetidine's antagonism of the normal negative feedback that androgens exert on gonadotropin secretion (Peden, Cargill, Browning, Saunders, &amp; Wormsley, 1979). Gynecomastia and even loss of libido that progressed to impotence have occasionally been reported in men taking cimetidine (Peden et al., 1979; Spence &amp; Celestin, 1979), but the occurrence of these disorders is very rare (Gifford, Aeugle, Myerson, &amp; Tannenbaum, 1980). In one survey, gynecomastia, the most frequent endocrine-related complaint, was reported in only 0.2% of over 9,000 patients taking cimetidine (Gifford et al., 1980).</q></cite></span></li><li id="cite_note-PlessisAgarwal2014-49"> <span id="mw-reference-text-cite_note-PlessisAgarwal2014-49" class="mw-reference-text"><cite id="CITEREFStefan_S._du_PlessisAshok_AgarwalEdmund_S._Sabanegh,_Jr.2014" class="citation book cs1">Stefan S. du Plessis; Ashok Agarwal; Edmund S. Sabanegh, Jr. (26 July 2014). <a href="javascript:if(confirm('https://books.google.com/books?id=-I4kBAAAQBAJ&pg=PA233  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=-I4kBAAAQBAJ&pg=PA233'" tppabs="https://books.google.com/books?id=-I4kBAAAQBAJ&pg=PA233" class="external text external"><i>Male Infertility: A Complete Guide to Lifestyle and Environmental Factors</i></a>. Springer. pp.<span>&nbsp;</span>233–. ISBN<span>&nbsp;</span><bdi>978-1-4939-1040-3</bdi>. <q>Like other antiandrogens, [cimetidine] leads to elevated gonadotropin levels by antagonizing the negative feedback control of gonadotropin secretion by testosterone [1, 34]. Cimetidine has been reported to have antiandrogenic effects ranging from gynecomastia to oligospermia [4]. In one clinical study, men administered cimetidine exhibited a significant reduction in sperm concentration compared to placebo-treated controls [35]. In another study of men receiving cimetidine for chronic duodenal ulcers, testosterone and FSH were elevated during treatment with cimetidine compared to both pre- and posttreatment levels. Moreover, these hormonal effects were associated with a reduction in mean sperm count compared to the period after drug withdrawal [34].</q></cite></span></li><li id="cite_note-GalbraithMichnovicz1989-50"> <span id="mw-reference-text-cite_note-GalbraithMichnovicz1989-50" class="mw-reference-text"><cite id="CITEREFGalbraithMichnovicz1989" class="citation journal cs1">Galbraith RA, Michnovicz JJ (August 1989). "The effects of cimetidine on the oxidative metabolism of estradiol". <i>The New England Journal of Medicine</i>. <b>321</b> (5): 269–74. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2FNEJM198908033210501  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2FNEJM198908033210501'" tppabs="https://doi.org/10.1056%2FNEJM198908033210501" class="external text external">10.1056/NEJM198908033210501</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2747769  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2747769'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2747769" class="external text external">2747769</a>.</cite></span></li><li id="cite_note-pmid1988774-51"> <span id="mw-reference-text-cite_note-pmid1988774-51" class="mw-reference-text"><cite id="CITEREFMichnoviczGalbraith1991" class="citation journal cs1">Michnovicz JJ, Galbraith RA (February 1991). "Cimetidine inhibits catechol estrogen metabolism in women". <i>Metabolism</i>. <b>40</b> (2): 170–4. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0026-0495%2891%2990169-W  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0026-0495%2891%2990169-W'" tppabs="https://doi.org/10.1016%2F0026-0495%2891%2990169-W" class="external text external">10.1016/0026-0495(91)90169-W</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1988774  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1988774'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1988774" class="external text external">1988774</a>.</cite></span></li><li id="cite_note-PescovitzWalvoord2007-52"> <span id="mw-reference-text-cite_note-PescovitzWalvoord2007-52" class="mw-reference-text"><cite id="CITEREFPescovitzWalvoord2007" class="citation book cs1">Pescovitz OH, Walvoord EC (6 June 2007). <a href="javascript:if(confirm('https://books.google.com/books?id=seYO1f1JgzYC&pg=PA203  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=seYO1f1JgzYC&pg=PA203'" tppabs="https://books.google.com/books?id=seYO1f1JgzYC&pg=PA203" class="external text external"><i>When Puberty is Precocious: Scientific and Clinical Aspects</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>203–. ISBN<span>&nbsp;</span><bdi>978-1-59745-499-5</bdi>.</cite></span></li><li id="cite_note-PolatCuhaci2014-53"> <span id="mw-reference-text-cite_note-PolatCuhaci2014-53" class="mw-reference-text"><cite id="CITEREFCuhaciPolatEvranosErsoy2014" class="citation journal cs1">Cuhaci N, Polat SB, Evranos B, Ersoy R, Cakir B (March 2014). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987263  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987263'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987263" class="external text external">"Gynecomastia: Clinical evaluation and management"</a>. <i>Indian Journal of Endocrinology and Metabolism</i>. <b>18</b> (2): 150–8. doi:<a href="javascript:if(confirm('https://doi.org/10.4103%2F2230-8210.129104  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4103%2F2230-8210.129104'" tppabs="https://doi.org/10.4103%2F2230-8210.129104" class="external text external">10.4103/2230-8210.129104</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987263  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987263'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987263" class="external text external">3987263</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24741509  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24741509'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24741509" class="external text external">24741509</a>.</cite></span></li><li id="cite_note-RendicCarlo2010-54"> <span id="mw-reference-text-cite_note-RendicCarlo2010-54" class="mw-reference-text"><cite id="CITEREFRendicDi_Carlo2010" class="citation journal cs1">Rendic S, Di Carlo FJ (2010). "Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors". <i>Drug Metabolism Reviews</i>. <b>29</b> (1–2): 413–580. doi:<a href="javascript:if(confirm('https://doi.org/10.3109%2F03602539709037591  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3109%2F03602539709037591'" tppabs="https://doi.org/10.3109%2F03602539709037591" class="external text external">10.3109/03602539709037591</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9187528  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9187528'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9187528" class="external text external">9187528</a>.</cite></span></li><li id="cite_note-pmid22862307-55"> <span id="mw-reference-text-cite_note-pmid22862307-55" class="mw-reference-text"><cite id="CITEREFDeepinderBraunstein2012" class="citation journal cs1">Deepinder F, Braunstein GD (September 2012). "Drug-induced gynecomastia: an evidence-based review". <i>Expert Opin Drug Saf</i>. <b>11</b> (5): 779–95. doi:<a href="javascript:if(confirm('https://doi.org/10.1517%2F14740338.2012.712109  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1517%2F14740338.2012.712109'" tppabs="https://doi.org/10.1517%2F14740338.2012.712109" class="external text external">10.1517/14740338.2012.712109</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22862307  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22862307'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22862307" class="external text external">22862307</a>. <q>Cimetidine. Spence and Celestin reported a 20% incidence of gynecomastia in a prospective study of 25 male duodenal ulcer patients treated with cimetidine 1.6 g/day [13]. Symptoms developed after 4 months of treatment and regressed within a month of stopping therapy. In another prospective cohort study involving 22 patients, cimetidine caused breast changes and erectile dysfunction in 60% of men which resolved completely in all cases when switched to ranitidine [14]. In the UK general practice database of over 80,000 men, the relative risk (RR) of gynecomastia among cimetidine users was 7.2 (95% confidence interval (CI 4.5 -- 11.3)) as compared with the non-users. Users with a daily dose ‡ 1000 mg had more than 40 times the risk of developing gynecomastia than the non-users. The period of highest risk was 7 -- 12 months after starting cimetidine treatment [15]. Cimetidine blocks the androgen receptors in the breast leading to decreased androgen action causing the growth of breast tissue because of ‘unopposed’ estrogen action [16]. Another possible mechanism includes decreased 2-hydroxylation of estrogen leading to elevated serum estrogen levels [17]. There also are reports of cimetidine blocking testosterone biosynthesis and causing elevated prolactin levels in individual cases [18].</q></cite></span></li><li id="cite_note-WattsFaingold2009-56"> <span id="mw-reference-text-cite_note-WattsFaingold2009-56" class="mw-reference-text"><cite id="CITEREFStephanie_WattsCarl_FaingoldGeorge_DunawayLynn_Crespo2009" class="citation book cs1">Stephanie Watts; Carl Faingold; George Dunaway; Lynn Crespo (1 April 2009). <a href="javascript:if(confirm('https://books.google.com/books?id=kfsrz_-OrMQC&pg=PA472  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=kfsrz_-OrMQC&pg=PA472'" tppabs="https://books.google.com/books?id=kfsrz_-OrMQC&pg=PA472" class="external text external"><i>Brody's Human Pharmacology - E-Book</i></a>. Elsevier Health Sciences. pp.<span>&nbsp;</span>472–. ISBN<span>&nbsp;</span><bdi>978-0-323-07575-6</bdi>. <q>The histamine receptor antagonist cimetidine, used to decrease gastric acid secretion in treatment of peptic ulcer disease and esophagitis (see Chapter 14), also acts as an antiandrogen. Thus it has been reported to produce gynecomastia when given in large doses, such as those used in the treatment of patients with Zollinger-Ellison syndrome. Gynecomastia occurs in less than 1% of patients treated with the doses used in peptic ulcer disease. Cimetidine interacts with ARs approximately 0.01% as effectively as testosterone and has been used with limited effectiveness to treat hirsutism in women.</q></cite></span></li><li id="cite_note-AltchekDeligdisch2003-57"> <span id="mw-reference-text-cite_note-AltchekDeligdisch2003-57" class="mw-reference-text"><cite id="CITEREFAlbert_AltchekLiane_DeligdischNathan_Kase2003" class="citation book cs1">Albert Altchek; Liane Deligdisch; Nathan Kase (4 September 2003). <a href="javascript:if(confirm('https://books.google.com/books?id=vds_TQpTIhoC&pg=PA351  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=vds_TQpTIhoC&pg=PA351'" tppabs="https://books.google.com/books?id=vds_TQpTIhoC&pg=PA351" class="external text external"><i>Diagnosis and Management of Ovarian Disorders</i></a>. Academic Press. pp.<span>&nbsp;</span>351–. ISBN<span>&nbsp;</span><bdi>978-0-08-049451-7</bdi>. <q>Cimetidine is a weak androgen receptor antagonist. A controlled clinical study has not found cimetidine to be effective in the treatment of hyperandrogenism.[123, 124] 5.</q></cite></span></li><li id="cite_note-PreglerDeCherney2002-58"> <span id="mw-reference-text-cite_note-PreglerDeCherney2002-58" class="mw-reference-text"><cite id="CITEREFJanet_P._PreglerAlan_H._DeCherney2002" class="citation book cs1">Janet P. Pregler; Alan H. DeCherney (2002). <a href="javascript:if(confirm('https://books.google.com/books?id=zC99_it1C5YC&pg=PA595  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=zC99_it1C5YC&pg=PA595'" tppabs="https://books.google.com/books?id=zC99_it1C5YC&pg=PA595" class="external text external"><i>Women's Health: Principles and Clinical Practice</i></a>. PMPH-USA. pp.<span>&nbsp;</span>595–. ISBN<span>&nbsp;</span><bdi>978-1-55009-170-0</bdi>. <q>Cimetidine is a histamine type 2 blocker, which also binds to the androgen receptor to inhibit its function." However, this antiandrogen activity of cimetidine is weak, and the clinical benefit of its use in women with hirsutism is minimal. Thus, this drug is not recommended for the treatment of hyperandrogenism.</q></cite></span></li><li id="cite_note-pmid20082945-59"> <span id="mw-reference-text-cite_note-pmid20082945-59" class="mw-reference-text"><cite id="CITEREFKatsambasDessinioti2010" class="citation journal cs1">Katsambas AD, Dessinioti C (2010). "Hormonal therapy for acne: why not as first line therapy? facts and controversies". <i>Clin. Dermatol</i>. <b>28</b> (1): 17–23. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.clindermatol.2009.03.006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.clindermatol.2009.03.006'" tppabs="https://doi.org/10.1016%2Fj.clindermatol.2009.03.006" class="external text external">10.1016/j.clindermatol.2009.03.006</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20082945  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20082945'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20082945" class="external text external">20082945</a>.</cite></span></li><li id="cite_note-60"> <span id="mw-reference-text-cite_note-60" class="mw-reference-text"><cite id="CITEREFScheinfeld2003" class="citation journal cs1">Scheinfeld N (March 2003). "Cimetidine: a review of the recent developments and reports in cutaneous medicine". <i>Dermatology Online Journal</i>. <b>9</b> (2): 4. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12639457  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12639457'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12639457" class="external text external">12639457</a>.</cite></span></li><li id="cite_note-ACS_Landmarks-61"> <span id="mw-reference-text-cite_note-ACS_Landmarks-61" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://archive.is/20121209003707/http://portal.acs.org/portal/PublicWebSite/education/whatischemistry/landmarks/cimetidinetagamet/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.is/20121209003707/http://portal.acs.org/portal/PublicWebSite/education/whatischemistry/landmarks/cimetidinetagamet/'" tppabs="https://archive.is/20121209003707/http://portal.acs.org/portal/PublicWebSite/education/whatischemistry/landmarks/cimetidinetagamet/" class="external text external">"Tagamet<sup>®</sup>: Discovery of Histamine H<sub>2</sub>-receptor Antagonists"</a>. <i>National Historic Chemical Landmarks</i>. American Chemical Society. Archived from <a href="javascript:if(confirm('http://portal.acs.org/portal/PublicWebSite/education/whatischemistry/landmarks/cimetidinetagamet/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://portal.acs.org/portal/PublicWebSite/education/whatischemistry/landmarks/cimetidinetagamet/'" tppabs="http://portal.acs.org/portal/PublicWebSite/education/whatischemistry/landmarks/cimetidinetagamet/" class="external text external">the original</a> on December 9, 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">June 25,</span> 2012</span>.</cite></span></li><li id="cite_note-Freemantle-62"> <span id="mw-reference-text-cite_note-Freemantle-62" class="mw-reference-text"><cite id="CITEREFFremantle" class="citation web cs1">Fremantle M. <a href="javascript:if(confirm('http://pubs.acs.org/cen/coverstory/83/8325/8325tagamet.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://pubs.acs.org/cen/coverstory/83/8325/8325tagamet.html'" tppabs="http://pubs.acs.org/cen/coverstory/83/8325/8325tagamet.html" class="external text external">"Tagamet"</a>. <i>Chemical and Engineering news</i><span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2013</span>.</cite></span></li><li id="cite_note-63"> <span id="mw-reference-text-cite_note-63" class="mw-reference-text"><cite id="CITEREFWhitney2006" class="citation news cs1">Whitney J (February 2006). <a href="javascript:if(confirm('https://web.archive.org/web/20080807114344/http://www.guernicamag.com/features/111/me_too_drugs/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20080807114344/http://www.guernicamag.com/features/111/me_too_drugs/'" tppabs="https://web.archive.org/web/20080807114344/http://www.guernicamag.com/features/111/me_too_drugs/" class="external text external">"Pharmaceutical Sales 101: Me-Too Drugs"</a>. <i>Guernica</i>. Archived from <a href="javascript:if(confirm('http://www.guernicamag.com/features/111/me_too_drugs/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guernicamag.com/features/111/me_too_drugs/'" tppabs="http://www.guernicamag.com/features/111/me_too_drugs/" class="external text external">the original</a> on 2008-08-07<span class="reference-accessdate">. Retrieved <span class="nowrap">2008-07-31</span></span>.</cite></span></li><li id="cite_note-64"> <span id="mw-reference-text-cite_note-64" class="mw-reference-text"><cite id="CITEREFRanii2011" class="citation news cs1">Ranii D (21 December 2011). <a href="javascript:if(confirm('https://web.archive.org/web/20120415192244/http://blogs.newsobserver.com/business/gsk-sells-bc-goodys-and-other-brands  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20120415192244/http://blogs.newsobserver.com/business/gsk-sells-bc-goodys-and-other-brands'" tppabs="https://web.archive.org/web/20120415192244/http://blogs.newsobserver.com/business/gsk-sells-bc-goodys-and-other-brands" class="external text external">"GSK sells BC, Goody's and other brands"</a>. <i>News &amp; Observer</i>. Archived from <a href="javascript:if(confirm('http://blogs.newsobserver.com/business/gsk-sells-bc-goodys-and-other-brands  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://blogs.newsobserver.com/business/gsk-sells-bc-goodys-and-other-brands'" tppabs="http://blogs.newsobserver.com/business/gsk-sells-bc-goodys-and-other-brands" class="external text external">the original</a> on 2012-04-15.</cite></span></li></ol></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><a href="javascript:if(confirm('https://archive.is/20121209003707/http://portal.acs.org/portal/PublicWebSite/education/whatischemistry/landmarks/cimetidinetagamet/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.is/20121209003707/http://portal.acs.org/portal/PublicWebSite/education/whatischemistry/landmarks/cimetidinetagamet/'" tppabs="https://archive.is/20121209003707/http://portal.acs.org/portal/PublicWebSite/education/whatischemistry/landmarks/cimetidinetagamet/" class="external text external">Tagamet<sup>®</sup>: Discovery of Histamine H<sub>2</sub>-receptor Antagonists</a> from American Chemical Society National Historic Chemical Landmarks</li></ul>

<div role="navigation" class="navbox" aria-labelledby="Drugs_for_peptic_ulcer_and_GERD/GORD_(A02B)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Drugs_for_peptic_ulcer_and_GERD/GORD_(A02B)" style="font-size:114%;margin:0 4em">Drugs for peptic ulcer and GERD/GORD (A02B)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">H<sub>2</sub> antagonists ("-tidine")</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Cimetidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cimetidine" title="Cimetidine">Cimetidine</a></li>
<li><a href="Famotidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Famotidine" title="Famotidine">Famotidine</a></li>
<li>Lafutidine</li>
<li>Lavoltidine (loxtidine)</li>
<li>Niperotidine</li>
<li><a href="Nizatidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nizatidine" title="Nizatidine">Nizatidine</a></li>
<li><a href="Ranitidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ranitidine" title="Ranitidine">Ranitidine</a><sup>#</sup></li>
<li>Roxatidine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Prostaglandins (E)/analogues ("-prost-")</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Misoprostol.htm" tppabs="https://ptable.com/wiki/compounds/A/Misoprostol" title="Misoprostol">Misoprostol</a></li>
<li>Enprostil</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Proton-pump inhibitors ("-prazole")</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Azeloprazole</li>
<li>Dexlansoprazole</li>
<li><a href="Esomeprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Esomeprazole" title="Esomeprazole">Esomeprazole</a></li>
<li>Ilaprazole</li>
<li><a href="Lansoprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Lansoprazole" title="Lansoprazole">Lansoprazole</a></li>
<li><a href="Omeprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Omeprazole" title="Omeprazole">Omeprazole</a><sup>#</sup></li>
<li><a href="Pantoprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Pantoprazole" title="Pantoprazole">Pantoprazole</a></li>
<li><span class="new">Picoprazole</span></li>
<li><a href="Rabeprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Rabeprazole" title="Rabeprazole">Rabeprazole</a></li>
<li>Tenatoprazole</li>
<li>Timoprazole</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Potassium-competitive acid blockers ("-prazan")</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><span class="new">Linaprazan</span></li>
<li>Revaprazan</li>
<li><span class="new">Soraprazan</span></li>
<li>Vonoprazan</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Aceglutamide aluminum</li>
<li>Acetoxolone</li>
<li>Alginic acid</li>
<li>Arbaclofen placarbil</li>
<li>Bismuth subcitrate</li>
<li><a href="Carbenoxolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbenoxolone" title="Carbenoxolone">Carbenoxolone</a></li>
<li><a href="Cetraxate.htm" tppabs="https://ptable.com/wiki/compounds/A/Cetraxate" title="Cetraxate">Cetraxate</a></li>
<li>Gefarnate</li>
<li>Lesogaberan</li>
<li><a href="Pirenzepine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pirenzepine" title="Pirenzepine">Pirenzepine</a></li>
<li>Proglumide</li>
<li><a href="Rebamipide.htm" tppabs="https://ptable.com/wiki/compounds/A/Rebamipide" title="Rebamipide">Rebamipide</a></li>
<li><a href="Sucralfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Sucralfate" title="Sucralfate">Sucralfate</a></li>
<li>Sulglicotide</li>
<li><a href="Telenzepine.htm" tppabs="https://ptable.com/wiki/compounds/A/Telenzepine" title="Telenzepine">Telenzepine</a></li>
<li>Teprenone</li>
<li>Troxipide</li>
<li>Zinc L-carnosine</li>
<li>Zolimidine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Combinations</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Bismuth subcitrate/metronidazole/tetracycline</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>See also: <i>Helicobacter pylori</i> eradication protocols</i></li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;"><div><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Histamine_receptor_modulators" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Histamine_receptor_modulators" style="font-size:114%;margin:0 4em">Histamine receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align: center;">H<sub>1</sub></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Agonists:</b> 2-Pyridylethylamine</li>
<li><a href="Betahistine.htm" tppabs="https://ptable.com/wiki/compounds/A/Betahistine" title="Betahistine">Betahistine</a></li>
<li><a href="Histamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Histamine" title="Histamine">Histamine</a></li>
<li>HTMT</li>
<li><span style="font-size:90%;">L</span>-Histidine</li>
<li>UR-AK49</li></ul>

<ul><li><b>Antagonists:</b> <i>First-generation:</i> 4-Methyldiphenhydramine</li>
<li><a href="Alimemazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Alimemazine" title="Alimemazine">Alimemazine</a></li>
<li><a href="Antazoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Antazoline" title="Antazoline">Antazoline</a></li>
<li><a href="Azatadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Azatadine" title="Azatadine">Azatadine</a></li>
<li>Bamipine</li>
<li><a href="Benzatropine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzatropine" title="Benzatropine">Benzatropine (benztropine)</a></li>
<li><a href="Bepotastine.htm" tppabs="https://ptable.com/wiki/compounds/A/Bepotastine" title="Bepotastine">Bepotastine</a></li>
<li><a href="Bromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Bromazine" title="Bromazine">Bromazine</a></li>
<li><a href="Brompheniramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Brompheniramine" title="Brompheniramine">Brompheniramine</a></li>
<li><a href="Buclizine.htm" tppabs="https://ptable.com/wiki/compounds/A/Buclizine" title="Buclizine">Buclizine</a></li>
<li>Captodiame</li>
<li><a href="Carbinoxamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbinoxamine" title="Carbinoxamine">Carbinoxamine</a></li>
<li><a href="Chlorcyclizine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorcyclizine" title="Chlorcyclizine">Chlorcyclizine</a></li>
<li>Chloropyramine</li>
<li><a href="Chlorothen.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorothen" title="Chlorothen">Chlorothen</a></li>
<li><a href="Chlorphenamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorphenamine" title="Chlorphenamine">Chlorphenamine</a></li>
<li>Chlorphenoxamine</li>
<li><a href="Cinnarizine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cinnarizine" title="Cinnarizine">Cinnarizine</a></li>
<li><a href="Clemastine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clemastine" title="Clemastine">Clemastine</a></li>
<li>Clobenzepam</li>
<li>Clocinizine</li>
<li>Cloperastine</li>
<li><a href="Cyclizine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclizine" title="Cyclizine">Cyclizine</a></li>
<li><a href="Cyproheptadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyproheptadine" title="Cyproheptadine">Cyproheptadine</a></li>
<li>Dacemazine</li>
<li><span class="new">Decloxizine</span></li>
<li>Deptropine</li>
<li><a href="Dexbrompheniramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dexbrompheniramine" title="Dexbrompheniramine">Dexbrompheniramine</a></li>
<li>Dexchlorpheniramine</li>
<li><a href="Dimenhydrinate.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimenhydrinate" title="Dimenhydrinate">Dimenhydrinate</a></li>
<li>Dimetindene</li>
<li><a href="Diphenhydramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diphenhydramine" title="Diphenhydramine">Diphenhydramine</a></li>
<li>Diphenylpyraline</li>
<li><a href="Doxylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Doxylamine" title="Doxylamine">Doxylamine</a></li>
<li>Embramine</li>
<li>Etodroxizine</li>
<li>Etybenzatropine (ethylbenztropine)</li>
<li>Etymemazine</li>
<li>Fenethazine</li>
<li><a href="Flunarizine.htm" tppabs="https://ptable.com/wiki/compounds/A/Flunarizine" title="Flunarizine">Flunarizine</a></li>
<li>Histapyrrodine</li>
<li>Homochlorcyclizine</li>
<li>Hydroxyethylpromethazine</li>
<li><a href="Hydroxyzine.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydroxyzine" title="Hydroxyzine">Hydroxyzine</a></li>
<li>Isopromethazine</li>
<li>Isothipendyl</li>
<li><a href="Meclozine.htm" tppabs="https://ptable.com/wiki/compounds/A/Meclozine" title="Meclozine" class="mw-redirect">Meclozine</a></li>
<li>Medrylamine</li>
<li><a href="Mepyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mepyramine" title="Mepyramine">Mepyramine (pyrilamine)</a></li>
<li><a href="Mequitazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mequitazine" title="Mequitazine">Mequitazine</a></li>
<li>Methafurylene</li>
<li><a href="Methapyrilene.htm" tppabs="https://ptable.com/wiki/compounds/A/Methapyrilene" title="Methapyrilene">Methapyrilene</a></li>
<li><a href="Methdilazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methdilazine" title="Methdilazine">Methdilazine</a></li>
<li>Moxastine</li>
<li><a href="Orphenadrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Orphenadrine" title="Orphenadrine">Orphenadrine</a></li>
<li><a href="Oxatomide.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxatomide" title="Oxatomide">Oxatomide</a></li>
<li>Oxomemazine</li>
<li>Perlapine</li>
<li><a href="Phenindamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenindamine" title="Phenindamine">Phenindamine</a></li>
<li><a href="Pheniramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pheniramine" title="Pheniramine">Pheniramine</a></li>
<li>Phenyltoloxamine</li>
<li>Pimethixene</li>
<li>Piperoxan</li>
<li>Pipoxizine</li>
<li><a href="Promethazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Promethazine" title="Promethazine">Promethazine</a></li>
<li><a href="Propiomazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Propiomazine" title="Propiomazine">Propiomazine</a></li>
<li>Pyrrobutamine</li>
<li>Talastine</li>
<li><a href="Thenalidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Thenalidine" title="Thenalidine">Thenalidine</a></li>
<li><a href="Thenyldiamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Thenyldiamine" title="Thenyldiamine">Thenyldiamine</a></li>
<li><a href="Thiazinamium_metilsulfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Thiazinamium" title="Thiazinamium" class="mw-redirect">Thiazinamium</a></li>
<li><a href="Thonzylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Thonzylamine" title="Thonzylamine">Thonzylamine</a></li>
<li>Tolpropamine</li>
<li><a href="Tripelennamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tripelennamine" title="Tripelennamine">Tripelennamine</a></li>
<li><a href="Triprolidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Triprolidine" title="Triprolidine">Triprolidine</a></li></ul>

<ul><li><i>Second/third-generation:</i> <a href="Acrivastine.htm" tppabs="https://ptable.com/wiki/compounds/A/Acrivastine" title="Acrivastine">Acrivastine</a></li>
<li><span class="new">Alinastine</span></li>
<li><a href="Astemizole.htm" tppabs="https://ptable.com/wiki/compounds/A/Astemizole" title="Astemizole">Astemizole</a></li>
<li><a href="Azelastine.htm" tppabs="https://ptable.com/wiki/compounds/A/Azelastine" title="Azelastine">Azelastine</a></li>
<li><span class="new">Bamirastine</span></li>
<li><span class="new">Barmastine</span></li>
<li><span class="new">Bepiastine</span></li>
<li><a href="Bepotastine.htm" tppabs="https://ptable.com/wiki/compounds/A/Bepotastine" title="Bepotastine">Bepotastine</a></li>
<li>Bilastine</li>
<li><span class="new">Cabastinen</span></li>
<li><span class="new">Carebastine</span></li>
<li><a href="Cetirizine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cetirizine" title="Cetirizine">Cetirizine</a></li>
<li><a href="Clemastine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clemastine" title="Clemastine">Clemastine</a></li>
<li>Clemizole</li>
<li>Clobenztropine</li>
<li><a href="Desloratadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Desloratadine" title="Desloratadine">Desloratadine</a></li>
<li><span class="new">Dorastine</span></li>
<li>Ebastine</li>
<li><span class="new">Efletirizine</span></li>
<li><a href="Emedastine.htm" tppabs="https://ptable.com/wiki/compounds/A/Emedastine" title="Emedastine">Emedastine</a></li>
<li><a href="Epinastine.htm" tppabs="https://ptable.com/wiki/compounds/A/Epinastine" title="Epinastine">Epinastine</a></li>
<li><a href="Fexofenadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fexofenadine" title="Fexofenadine">Fexofenadine</a></li>
<li><span class="new">Flezelastine</span></li>
<li><a href="Ketotifen.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketotifen" title="Ketotifen">Ketotifen</a></li>
<li>Latrepirdine</li>
<li><a href="Levocabastine.htm" tppabs="https://ptable.com/wiki/compounds/A/Levocabastine" title="Levocabastine">Levocabastine</a></li>
<li>Levocetirizine</li>
<li><span class="new">Linetastine</span></li>
<li><a href="Loratadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Loratadine" title="Loratadine">Loratadine</a></li>
<li><span class="new">Mapinastine</span></li>
<li>Mebhydrolin</li>
<li>Mizolastine</li>
<li>Moxastine</li>
<li><span class="new">Noberastine</span></li>
<li><span class="new">Octastine</span></li>
<li><a href="Olopatadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Olopatadine" title="Olopatadine">Olopatadine</a></li>
<li><span class="new">Perastine</span></li>
<li><span class="new">Pibaxizine</span></li>
<li><span class="new">Piclopastine</span></li>
<li>Quifenadine (phencarol)</li>
<li><span class="new">Rocastine</span></li>
<li>Rupatadine</li>
<li>Setastine</li>
<li><span class="new">Sequifenadine (bicarphen)</span></li>
<li>Talastine</li>
<li><span class="new">Temelastine</span></li>
<li><a href="Terfenadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Terfenadine" title="Terfenadine">Terfenadine</a></li>
<li><span class="new">Vapitadine</span></li>
<li><span class="new">Zepastine</span></li></ul>

<ul><li><i>Others:</i> Atypical antipsychotics (e.g., <a href="Aripiprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Aripiprazole" title="Aripiprazole">aripiprazole</a>, asenapine, brexpiprazole, brilaroxazine, <a href="Clozapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clozapine" title="Clozapine">clozapine</a>, iloperidone, <a href="Olanzapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Olanzapine" title="Olanzapine">olanzapine</a>, <a href="Paliperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Paliperidone" title="Paliperidone">paliperidone</a>, <a href="Quetiapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quetiapine" title="Quetiapine">quetiapine</a>, <a href="Risperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Risperidone" title="Risperidone">risperidone</a>, <a href="Ziprasidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Ziprasidone" title="Ziprasidone">ziprasidone</a>, zotepine)</li>
<li><a href="Phenylpiperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylpiperazine" title="Phenylpiperazine">Phenylpiperazine</a> antidepressants (e.g., hydroxynefazodone, <a href="Nefazodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Nefazodone" title="Nefazodone">nefazodone</a>, <a href="Trazodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Trazodone" title="Trazodone">trazodone</a>, triazoledione)</li>
<li>Tetracyclic antidepressants (e.g., <a href="Amoxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amoxapine" title="Amoxapine">amoxapine</a>, <a href="Loxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Loxapine" title="Loxapine">loxapine</a>, <a href="Maprotiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Maprotiline" title="Maprotiline">maprotiline</a>, <a href="Mianserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mianserin" title="Mianserin">mianserin</a>, <a href="Mirtazapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mirtazapine" title="Mirtazapine">mirtazapine</a>, oxaprotiline)</li>
<li>Tricyclic antidepressants (e.g., <a href="Amitriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Amitriptyline" title="Amitriptyline">amitriptyline</a>, butriptyline, <a href="Clomipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomipramine" title="Clomipramine">clomipramine</a>, desipramine, dosulepin (dothiepin), <a href="Doxepin.htm" tppabs="https://ptable.com/wiki/compounds/A/Doxepin" title="Doxepin">doxepin</a>, <a href="Imipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Imipramine" title="Imipramine">imipramine</a>, iprindole, lofepramine, <a href="Nortriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Nortriptyline" title="Nortriptyline">nortriptyline</a>, <a href="Protriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Protriptyline" title="Protriptyline">protriptyline</a>, <a href="Trimipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Trimipramine" title="Trimipramine">trimipramine</a>)</li>
<li>Typical antipsychotics (e.g., <a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">chlorpromazine</a>, <a href="Flupentixol.htm" tppabs="https://ptable.com/wiki/compounds/A/Flupenthixol" title="Flupenthixol" class="mw-redirect">flupenthixol</a>, <a href="Fluphenazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluphenazine" title="Fluphenazine">fluphenazine</a>, <a href="Loxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Loxapine" title="Loxapine">loxapine</a>, <a href="Perphenazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Perphenazine" title="Perphenazine">perphenazine</a>, <a href="Prochlorperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Prochlorperazine" title="Prochlorperazine">prochlorperazine</a>, <a href="Thioridazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Thioridazine" title="Thioridazine">thioridazine</a>, <a href="Thiothixene.htm" tppabs="https://ptable.com/wiki/compounds/A/Thiothixene" title="Thiothixene" class="mw-redirect">thiothixene</a>)</li></ul>

<ul><li><i>Unknown/unsorted:</i> <span class="new">Azanator</span></li>
<li><span class="new">Belarizine</span></li>
<li><span class="new">Elbanizine</span></li>
<li><span class="new">Flotrenizine</span></li>
<li><span class="new">GSK1004723</span></li>
<li><span class="new">Napactadine</span></li>
<li><span class="new">Tagorizine</span></li>
<li><span class="new">Trelnarizine</span></li>
<li><span class="new">Trenizine</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align: center;">H<sub>2</sub></th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Agonists:</b> Amthamine</li>
<li><a href="Betazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Betazole" title="Betazole">Betazole</a></li>
<li>Dimaprit</li>
<li><a href="Histamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Histamine" title="Histamine">Histamine</a></li>
<li>HTMT</li>
<li>Impromidine</li>
<li><span style="font-size:90%;">L</span>-Histidine</li>
<li>UR-AK49</li></ul>

<ul><li><b>Antagonists:</b> <span class="new">Bisfentidine</span></li>
<li>Burimamide</li>
<li><a href="Cimetidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cimetidine" title="Cimetidine">Cimetidine</a></li>
<li><span class="new">Dalcotidine</span></li>
<li><span class="new">Donetidine</span></li>
<li>Ebrotidine</li>
<li><span class="new">Etintidine</span></li>
<li><a href="Famotidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Famotidine" title="Famotidine">Famotidine</a></li>
<li><span class="new">Isolamtidine</span></li>
<li>Lafutidine</li>
<li><span class="new">Lamtidine</span></li>
<li>Lavoltidine (loxtidine)</li>
<li>Lupitidine</li>
<li>Metiamide</li>
<li><span class="new">Mifentidine</span></li>
<li>Niperotidine</li>
<li><a href="Nizatidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nizatidine" title="Nizatidine">Nizatidine</a></li>
<li><span class="new">Osutidine</span></li>
<li>Oxmetidine</li>
<li><span class="new">Pibutidine</span></li>
<li><span class="new">Quisultazine (quisultidine)</span></li>
<li><span class="new">Ramixotidine</span></li>
<li><a href="Ranitidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ranitidine" title="Ranitidine">Ranitidine</a></li>
<li>Roxatidine</li>
<li>Sufotidine</li>
<li><span class="new">Tiotidine</span></li>
<li><span class="new">Tuvatidine</span></li>
<li><span class="new">Venritidine</span></li>
<li><span class="new">Xaltidine</span></li>
<li>Zolantidine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align: center;">H<sub>3</sub></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Agonists:</b> α-Methylhistamine</li>
<li>Cipralisant</li>
<li><a href="Histamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Histamine" title="Histamine">Histamine</a></li>
<li>Imetit</li>
<li>Immepip</li>
<li>Immethridine</li>
<li><span style="font-size:90%;">L</span>-Histidine</li>
<li>Methimepip</li>
<li>Proxyfan</li></ul>

<ul><li><b>Antagonists:</b> A-349821</li>
<li>A-423579</li>
<li>ABT-239</li>
<li><span class="new">ABT-652</span></li>
<li><span class="new">AZD5213</span></li>
<li><span class="new">Bavisant</span></li>
<li><a href="Betahistine.htm" tppabs="https://ptable.com/wiki/compounds/A/Betahistine" title="Betahistine">Betahistine</a></li>
<li>Burimamide</li>
<li>Ciproxifan</li>
<li>Clobenpropit</li>
<li>Conessine</li>
<li><span class="new">Enerisant</span></li>
<li>GSK-189254</li>
<li>Impentamine</li>
<li>Iodophenpropit</li>
<li><span class="new">Irdabisant</span></li>
<li>JNJ-5207852</li>
<li>NNC 38-1049</li>
<li>PF-03654746</li>
<li>Pitolisant</li>
<li>SCH-79687</li>
<li>Thioperamide</li>
<li>VUF-5681</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align: center;">H<sub>4</sub></th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Agonists:</b> 4-Methylhistamine</li>
<li>α-Methylhistamine</li>
<li><a href="Histamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Histamine" title="Histamine">Histamine</a></li>
<li><span style="font-size:90%;">L</span>-Histidine</li>
<li>OUP-16</li>
<li>VUF-8430</li></ul>

<ul><li><b>Antagonists:</b> JNJ-7777120</li>
<li><a href="Mianserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mianserin" title="Mianserin">Mianserin</a></li>
<li><span class="new">Seliforant</span></li>
<li>Thioperamide</li>
<li><span class="new">Toreforant</span></li>
<li>VUF-6002</li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div><i><b>See also:</b> Receptor/signaling modulators • Monoamine metabolism modulators • Monoamine reuptake inhibitors</i></div></td></tr></tbody></table></div><span>
</span>
<div role="navigation" class="navbox" aria-labelledby="Androgen_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Androgen_receptor_modulators" style="font-size:114%;margin:0 4em">Androgen receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>AR</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Agonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Testosterone derivatives:</i> <a href="4-Androstenediol.htm" tppabs="https://ptable.com/wiki/compounds/A/4-Androstenediol" title="4-Androstenediol">4-Androstenediol</a></li>
<li>4-Dehydroepiandrosterone (4-DHEA)</li>
<li>4-Hydroxytestosterone</li>
<li><span class="new">4,17α-Dimethyltestosterone</span></li>
<li>5-Androstenedione</li>
<li>11-Ketotestosterone</li>
<li>11β-Hydroxyandrostenedione</li>
<li><a href="Adrenosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Adrenosterone" title="Adrenosterone">Adrenosterone (11-ketoandrostenedione, 11-oxoandrostenedione)</a></li>
<li><a href="5-Androstenediol.htm" tppabs="https://ptable.com/wiki/compounds/A/5-Androstenediol" title="5-Androstenediol" class="mw-redirect">Androstenediol (5-androstenediol)</a>
<ul><li>Androstenediol 3β-acetate</li>
<li>Androstenediol 17β-acetate</li>
<li>Androstenediol diacetate</li>
<li>Androstenediol dipropionate</li></ul></li>
<li><a href="Androstenedione.htm" tppabs="https://ptable.com/wiki/compounds/A/4-Androstenedione" title="4-Androstenedione" class="mw-redirect">Androstenedione (4-androstenedione)</a></li>
<li>Atamestane</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Boldenone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Boldenone'" tppabs="https://ptable.com/wiki/compounds/A/Boldenone" title="Boldenone">Boldenone</a>
<ul><li>Boldenone undecylenate</li></ul></li>
<li>Boldione (1,4-androstadienedione)</li>
<li><a href="Clostebol.htm" tppabs="https://ptable.com/wiki/compounds/A/Clostebol" title="Clostebol">Clostebol</a>
<ul><li>Clostebol acetate</li>
<li>Clostebol caproate</li>
<li>Clostebol propionate</li></ul></li>
<li>Cloxotestosterone
<ul><li>Cloxotestosterone acetate</li></ul></li>
<li>Dehydroandrosterone</li>
<li><a href="Dehydroepiandrosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone" title="Dehydroepiandrosterone">DHEA (androstenolone, prasterone; 5-DHEA)</a>
<ul><li>DHEA enanthate (prasterone enanthate)</li>
<li><a href="Dehydroepiandrosterone_sulfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone_sulfate" title="Dehydroepiandrosterone sulfate">DHEA sulfate</a></li></ul></li>
<li><a href="Exemestane.htm" tppabs="https://ptable.com/wiki/compounds/A/Exemestane" title="Exemestane">Exemestane</a></li>
<li><a href="Formestane.htm" tppabs="https://ptable.com/wiki/compounds/A/Formestane" title="Formestane">Formestane</a></li>
<li>Plomestane</li>
<li>Quinbolone</li>
<li>Silandrone</li>
<li>Testosterone<sup>#</sup> (+dutasteride)
<ul><li>Testosterone esters</li>
<li>Polytestosterone phloretin phosphate</li></ul></li></ul>

<ul><li><i>5α-Dihydrotestosterone derivatives:</i> 1-Androstenediol</li>
<li>1-Androstenedione</li>
<li>1-Androsterone (1-andro, 1-DHEA)</li>
<li>1-Testosterone</li>
<li>3α-Androstanediol</li>
<li>5α-Androst-2-en-17-one</li>
<li>7β-Hydroxyepiandrosterone</li>
<li>11-Ketodihydrotestosterone</li>
<li><a href="Androsterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Androsterone" title="Androsterone">Androsterone</a></li>
<li>Bolazine
<ul><li>Bolazine capronate</li></ul></li>
<li><span class="new">Dihydroethyltestosterone</span></li>
<li>Dihydrofluoxymesterone</li>
<li><span class="new">Dihydromethylandrostenediol</span></li>
<li><a href="Dihydrotestosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydrotestosterone" title="Dihydrotestosterone">Dihydrotestosterone (DHT)</a> (androstanolone, stanolone)
<ul><li>Dihydrotestosterone esters</li></ul></li>
<li><a href="Drostanolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Drostanolone" title="Drostanolone">Drostanolone</a>
<ul><li>Drostanolone propionate</li></ul></li>
<li><a href="Epiandrosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Epiandrosterone" title="Epiandrosterone">Epiandrosterone</a></li>
<li>Epitiostanol</li>
<li>Mepitiostane</li>
<li>Mesabolone</li>
<li><a href="Mesterolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mesterolone" title="Mesterolone">Mesterolone</a>
<ul><li>Mesterolone cipionate</li></ul></li>
<li>Methyldiazinol</li>
<li>Nisterime
<ul><li>Nisterime acetate</li></ul></li>
<li>Prostanozol</li>
<li>Stenbolone
<ul><li>Stenbolone acetate</li></ul></li>
<li>Testifenon (testiphenon, testiphenone)</li></ul>

<ul><li><i>19-Nortestosterone derivatives:</i> 7α-Methyl-19-norandrostenedione (MENT dione, trestione)</li>
<li>11β-Methyl-19-nortestosterone
<ul><li>11β-Methyl-19-nortestosterone dodecylcarbonate</li></ul></li>
<li>19-Nor-5-androstenediol</li>
<li>19-Nor-5-androstenedione</li>
<li>19-Nordehydroepiandrosterone</li>
<li>Bolandiol
<ul><li>Bolandiol dipropionate</li></ul></li>
<li>Bolandione (19-nor-4-androstenedione)</li>
<li>Bolmantalate (nandrolone adamantoate)</li>
<li>Dienedione</li>
<li>Dienolone</li>
<li>Dimethandrolone
<ul><li>Dimethandrolone buciclate</li>
<li>Dimethandrolone dodecylcarbonate</li>
<li>Dimethandrolone undecanoate</li></ul></li>
<li>LS-1727 (nandrolone 17β-<i>N</i>-(2-chloroethyl)-<i>N</i>-nitrosocarbamate)</li>
<li>Methoxydienone (methoxygonadiene)</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Nandrolone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Nandrolone'" tppabs="https://ptable.com/wiki/compounds/A/Nandrolone" title="Nandrolone">Nandrolone</a>
<ul><li>Nandrolone esters</li></ul></li>
<li>Norclostebol
<ul><li>Norclostebol acetate</li></ul></li>
<li>Normethandrone (methylestrenolone, normethisterone)</li>
<li><a href="Oxabolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxabolone" title="Oxabolone">Oxabolone</a>
<ul><li><a href="Oxabolone_cipionate.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxabolone_cipionate" title="Oxabolone cipionate">Oxabolone cipionate (oxabolone cypionate)</a></li></ul></li>
<li>Trenbolone
<ul><li>Trenbolone acetate</li>
<li>Trenbolone enanthate</li>
<li>Trenbolone hexahydrobenzylcarbonate</li>
<li>Trenbolone undecanoate</li></ul></li>
<li>Trendione</li>
<li>Trestolone (MENT)
<ul><li>Trestolone acetate</li>
<li>Trestolone enanthate</li></ul></li></ul>

<ul><li><i>5α-Dihydro-19-nortestosterone derivatives:</i> 5α-Dihydronandrolone</li>
<li><span class="new">5α-Dihydrotrestolone</span></li>
<li>19-Norandrosterone</li></ul>

<ul><li><i>17α-Alkylated testosterone derivatives:</i> <a href="Bolasterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Bolasterone" title="Bolasterone">Bolasterone</a></li>
<li><a href="Calusterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Calusterone" title="Calusterone">Calusterone</a></li>
<li>Chlorodehydromethylandrostenediol (CDMA)</li>
<li>Chlorodehydromethyltestosterone (CDMT)</li>
<li>Chloromethylandrostenediol (CMA)</li>
<li>Enestebol</li>
<li>Ethyltestosterone</li>
<li><a href="Fluoxymesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluoxymesterone" title="Fluoxymesterone">Fluoxymesterone</a></li>
<li><a href="Formebolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Formebolone" title="Formebolone">Formebolone</a></li>
<li>Hydroxystenozole</li>
<li>Metandienone (methandrostenolone)</li>
<li>Methandriol (methylandrostenediol)
<ul><li>Methandriol bisenanthoyl acetate</li>
<li>Methandriol diacetate</li>
<li>Methandriol dipropionate</li>
<li>Methandriol propionate</li></ul></li>
<li>Methylclostebol (chloromethyltestosterone)</li>
<li><a href="Methyltestosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methyltestosterone" title="Methyltestosterone">Methyltestosterone</a> (+esterified estrogens)
<ul><li>Methyltestosterone 3-hexyl ether</li></ul></li>
<li>Oxymesterone</li>
<li>Penmesterol</li>
<li>Tiomesterone</li></ul>

<ul><li><i>17α-Alkylated 5α-dihydrotestosterone derivatives:</i> Androisoxazole</li>
<li>Desoxymethyltestosterone</li>
<li><a href="Furazabol.htm" tppabs="https://ptable.com/wiki/compounds/A/Furazabol" title="Furazabol">Furazabol</a></li>
<li>Mebolazine (dimethazine)</li>
<li><a href="Mestanolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mestanolone" title="Mestanolone">Mestanolone</a></li>
<li>Metenolone
<ul><li>Metenolone acetate</li>
<li>Metenolone enanthate</li></ul></li>
<li>Methasterone</li>
<li>Methyl-1-testosterone</li>
<li>Methylepitiostanol</li>
<li>Methylstenbolone</li>
<li><a href="Oxandrolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxandrolone" title="Oxandrolone">Oxandrolone</a></li>
<li><a href="Oxymetholone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxymetholone" title="Oxymetholone">Oxymetholone</a></li>
<li><a href="Stanozolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Stanozolol" title="Stanozolol">Stanozolol</a></li></ul>

<ul><li><i>17α-Alkylated 19-nortestosterone derivatives:</i> Bolenol</li>
<li>Dimethyldienolone</li>
<li>Dimethyltrienolone</li>
<li>Ethyldienolone</li>
<li><a href="Ethylestrenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethylestrenol" title="Ethylestrenol">Ethylestrenol</a></li>
<li>Methyldienolone</li>
<li>Methylhydroxynandrolone (MOHN, MHN)</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Metribolone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Metribolone'" tppabs="https://ptable.com/wiki/compounds/A/Metribolone" title="Metribolone">Metribolone</a></li>
<li>Mibolerone</li>
<li>Norboletone</li>
<li>Norethandrolone</li>
<li>Propetandrol</li>
<li>RU-2309</li>
<li>Tetrahydrogestrinone</li></ul>

<ul><li><i>17α-Alkylated 5α-dihydro-19-nortestosterone derivatives:</i> 5α-Dihydronorethandrolone</li>
<li>5α-Dihydronormethandrone</li></ul>

<ul><li><i>17α-Vinyltestosterone derivatives:</i> Norvinisterone (vinylnortestosterone)</li></ul>

<ul><li><i>17α-Vinyl-19-nortestosterone derivatives:</i> Vinyltestosterone</li></ul>

<ul><li><i>17α-Ethynyltestosterone derivatives:</i> <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Danazol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Danazol'" tppabs="https://ptable.com/wiki/compounds/A/Danazol" title="Danazol">Danazol</a></li>
<li>Ethinylandrostenediol
<ul><li>Ethandrostate</li></ul></li>
<li><a href="Ethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethisterone" title="Ethisterone">Ethisterone (ethynyltestosterone)</a></li></ul>

<ul><li><i>5α-Dihydro-17α-ethynyltestosterone derivatives:</i> 17α-Ethynyl-3α-androstanediol</li>
<li>17α-Ethynyl-3β-androstanediol</li>
<li>Dihydroethisterone</li></ul>

<ul><li><i>17α-Ethynyl-19-nortestosterone derivatives:</i> Δ<sup>4</sup>-Tibolone</li>
<li><a href="Desogestrel.htm" tppabs="https://ptable.com/wiki/compounds/A/Desogestrel" title="Desogestrel">Desogestrel</a></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Etonogestrel  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Etonogestrel'" tppabs="https://ptable.com/wiki/compounds/A/Etonogestrel" title="Etonogestrel">Etonogestrel</a></li>
<li>Etynodiol
<ul><li><a href="Etynodiol_diacetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Etynodiol_diacetate" title="Etynodiol diacetate">Etynodiol diacetate</a></li></ul></li>
<li><a href="Gestodene.htm" tppabs="https://ptable.com/wiki/compounds/A/Gestodene" title="Gestodene">Gestodene</a></li>
<li><a href="Gestrinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Gestrinone" title="Gestrinone">Gestrinone</a></li>
<li><a href="Levonorgestrel.htm" tppabs="https://ptable.com/wiki/compounds/A/Levonorgestrel" title="Levonorgestrel">Levonorgestrel</a></li>
<li>Levonorgestrel esters (e.g., levonorgestrel butanoate)</li>
<li>Lynestrenol
<ul><li>Lynestrenol phenylpropionate</li></ul></li>
<li><a href="Norethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Norethisterone" title="Norethisterone">Norethisterone</a></li>
<li>Norethisterone esters (e.g., norethisterone acetate, norethisterone enanthate)</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Norgestrel  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Norgestrel'" tppabs="https://ptable.com/wiki/compounds/A/Norgestrel" title="Norgestrel">Norgestrel</a></li>
<li>Norgestrienone</li>
<li>Quingestanol
<ul><li>Quingestanol acetate</li></ul></li>
<li>Tibolone</li></ul>

<ul><li><i>5α-Dihydro-17α-ethynyl-19-nortestosterone derivatives:</i> 5α-Dihydrolevonorgestrel</li>
<li>5α-Dihydronorethisterone</li></ul>

<ul><li><i>Progesterone derivatives:</i> 6α-Methylprogesterone</li>
<li><a href="Medroxyprogesterone_acetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">Medroxyprogesterone acetate</a></li>
<li>Megestrol acetate</li></ul>

<ul><li><i>Others/unsorted:</i> 3-Keto-5α-abiraterone</li>
<li><a href="Androstane.htm" tppabs="https://ptable.com/wiki/compounds/A/5%CE%B1-Androstane" title="5α-Androstane" class="mw-redirect">5α-Androstane</a></li>
<li>Alternariol</li>
<li>Cl-4AS-1</li>
<li>Drupanol</li>
<li><a href="Trilostane.htm" tppabs="https://ptable.com/wiki/compounds/A/Trilostane" title="Trilostane">Trilostane</a></li>
<li>ZM-182345</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Mixed<br>(<abbr>SARMs</abbr>)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Nonsteroidal:</i> <span class="new">198RL26</span></li>
<li><span class="new">ACP-105</span></li>
<li><span class="new">AC-262536</span></li>
<li>Acetothiolutamide</li>
<li>Andarine (acetamidoxolutamide, androxolutamide, GTx-007, S-4)</li>
<li><span class="new">BMS-564929</span></li>
<li><span class="new">DTIB</span></li>
<li>Enobosarm (ostarine, MK-2866, GTx-024, S-22)</li>
<li><span class="new">FTBU-1</span></li>
<li>GSK2881078</li>
<li><span class="new">GSK-4336A</span></li>
<li><span class="new">GSK-8698</span></li>
<li>LG-121071 (LGD-121071)</li>
<li>LGD-2226</li>
<li><span class="new">LGD-2941 (LGD-122941)</span></li>
<li>LGD-3303</li>
<li>LGD-4033</li>
<li>LY-2452473</li>
<li><span class="new">JNJ-26146900</span></li>
<li>JNJ-28330835</li>
<li><span class="new">JNJ-37654032</span></li>
<li><span class="new">ORM-11984</span></li>
<li><span class="new">R-1</span></li>
<li>RAD140</li>
<li>RU-59063</li>
<li><span class="new">S-1</span></li>
<li>S-23</li>
<li>S-40503</li>
<li><span class="new">S-101479</span></li>
<li>Triclosan</li></ul>

<ul><li><i>Steroidal:</i> <span class="new">EM-9017</span></li>
<li>MK-0773</li>
<li>TFM-4AS-1</li>
<li>YK-11</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Antagonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Steroidal:</i> 7α-Thioprogesterone</li>
<li>7α-Thiospironolactone</li>
<li>7α-Thiomethylspironolactone</li>
<li>11α-Hydroxyprogesterone</li>
<li>15β-Hydroxycyproterone acetate</li>
<li>Abiraterone</li>
<li>Abiraterone acetate</li>
<li>Allyltestosterone</li>
<li>Benorterone</li>
<li>BOMT</li>
<li>Canrenoic acid</li>
<li>Canrenone</li>
<li>Chlormadinone acetate</li>
<li>Clascoterone</li>
<li>Clometerone</li>
<li><a href="Cyproheptadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyproheptadine" title="Cyproheptadine">Cyproheptadine</a></li>
<li><a href="Cyproterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyproterone" title="Cyproterone">Cyproterone</a></li>
<li>Cyproterone acetate</li>
<li>Delanterone</li>
<li>Delmadinone acetate</li>
<li>Dicirenone</li>
<li>Dienogest</li>
<li><a href="Drospirenone.htm" tppabs="https://ptable.com/wiki/compounds/A/Drospirenone" title="Drospirenone">Drospirenone</a></li>
<li>DU-41165</li>
<li>Edogestrone</li>
<li><span class="new">EM-4350</span></li>
<li>EM-5854</li>
<li><span class="new">EM-5855</span></li>
<li><span class="new">EM-6537</span></li>
<li>Epitestosterone</li>
<li>Galeterone</li>
<li>Guggulsterone</li>
<li>Medrogestone</li>
<li>Megestrol acetate</li>
<li>Mespirenone</li>
<li>Metogest</li>
<li>Mexrenone</li>
<li><a href="Mifepristone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mifepristone" title="Mifepristone">Mifepristone</a></li>
<li>Nomegestrol acetate</li>
<li>Nordinone</li>
<li>Osaterone</li>
<li>Osaterone acetate</li>
<li>Oxendolone</li>
<li>Potassium canrenoate</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Promegestone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Promegestone'" tppabs="https://ptable.com/wiki/compounds/A/Promegestone" title="Promegestone">Promegestone</a></li>
<li>Prorenone</li>
<li>Rosterolone</li>
<li><span class="new">RU-15328</span></li>
<li>SC-5233 (spirolactone)</li>
<li><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a></li>
<li>Spirorenone</li>
<li>Spiroxasone</li>
<li>Topterone</li>
<li>Trimegestone</li>
<li>Trimethyltrienolone (R-2956)</li>
<li>Zanoterone</li></ul>

<ul><li><i>Nonsteroidal:</i> 5<i>N</i>-Bicalutamide</li>
<li>AA560</li>
<li><span class="new">Antarlides</span></li>
<li><span class="new">Arabilin</span></li>
<li>Apalutamide</li>
<li>Atraric acid</li>
<li><span class="new">AZD-3514</span></li>
<li>Bakuchiol</li>
<li><span class="new">BAY-1024767</span></li>
<li><a href="Bicalutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bicalutamide" title="Bicalutamide">Bicalutamide</a></li>
<li><a href="Bisphenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol" title="Bisphenol">Bisphenols</a> (e.g., <a href="Bisphenol_A_diglycidyl_ether.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol_A_diglycidyl_ether" title="Bisphenol A diglycidyl ether">BADGE</a>, <span class="new">BFDGE</span>, <a href="Bisphenol_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol_A" title="Bisphenol A">bisphenol A</a>, bisphenol F, <a href="Bisphenol_S.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol_S" title="Bisphenol S">bisphenol S</a>)</li>
<li><span class="new">BMS-501949</span></li>
<li><span class="new">BMS-570511</span></li>
<li>BMS-641988</li>
<li><span class="new">CH5137291</span></li>
<li><a href="Cimetidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cimetidine" title="Cimetidine">Cimetidine</a></li>
<li>Cioteronel</li>
<li>Cyanonilutamide</li>
<li>Darolutamide</li>
<li>DDT (via metabolite p,p’-DDE)</li>
<li><a href="Dieldrin.htm" tppabs="https://ptable.com/wiki/compounds/A/Dieldrin" title="Dieldrin">Dieldrin</a></li>
<li>DIMP</li>
<li><a href="Endosulfan.htm" tppabs="https://ptable.com/wiki/compounds/A/Endosulfan" title="Endosulfan">Endosulfan</a></li>
<li>Enzalutamide</li>
<li>EPI-001</li>
<li>EPI-7386</li>
<li><a href="Fenarimol.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenarimol" title="Fenarimol">Fenarimol</a></li>
<li><a href="Flutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Flutamide" title="Flutamide">Flutamide</a></li>
<li>Hydroxyflutamide</li>
<li>Inocoterone</li>
<li>Inocoterone acetate</li>
<li><a href="Ketoconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketoconazole" title="Ketoconazole">Ketoconazole</a></li>
<li>Ketodarolutamide</li>
<li>Lavender oil</li>
<li><span class="new">LG-105</span></li>
<li>LG-120907</li>
<li><span class="new">LGD-1331</span></li>
<li>Linuron</li>
<li><a href="Methiocarb.htm" tppabs="https://ptable.com/wiki/compounds/A/Methiocarb" title="Methiocarb">Methiocarb</a></li>
<li><span class="new"><i>N</i>-Butylbenzenesulfonamide</span></li>
<li><i>N</i>-Desmethylapalutamide</li>
<li><i>N</i>-Desmethylenzalutamide</li>
<li><a href="Nilutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nilutamide" title="Nilutamide">Nilutamide</a></li>
<li><span class="new">ONC1-13B</span></li>
<li>Pentomone</li>
<li><span class="new">PF-998425</span></li>
<li><a href="Phenothrin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenothrin" title="Phenothrin">Phenothrin</a></li>
<li>Prochloraz</li>
<li><a href="Procymidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Procymidone" title="Procymidone">Procymidone</a></li>
<li>Proxalutamide</li>
<li>Ralaniten (EPI-002)</li>
<li>Ralaniten acetate (EPI-506)</li>
<li>RD-162</li>
<li><span class="new">Ro 2-7239</span></li>
<li><span class="new">Ro 5-2537</span></li>
<li>RU-22930</li>
<li>RU-56187</li>
<li>RU-57073</li>
<li>RU-58642</li>
<li>RU-58841</li>
<li>Seviteronel</li>
<li><a href="Thalidomide.htm" tppabs="https://ptable.com/wiki/compounds/A/Thalidomide" title="Thalidomide">Thalidomide</a></li>
<li>Topilutamide (fluridil)</li>
<li><a href="Valproic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Valproic_acid" title="Valproic acid" class="mw-redirect">Valproic acid</a></li>
<li>Vinclozolin</li>
<li><span class="new">YM-580</span></li>
<li><span class="new">YM-92088</span></li>
<li><span class="new">YM-175735</span></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>GPRC6A</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center;">Agonists</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Cations (incl. aluminum, <a href="Calcium.htm" tppabs="https://ptable.com/wiki/compounds/A/Calcium" title="Calcium">calcium</a>, <a href="Gadolinium.htm" tppabs="https://ptable.com/wiki/compounds/A/Gadolinium" title="Gadolinium">gadolinium</a>, <a href="Magnesium.htm" tppabs="https://ptable.com/wiki/compounds/A/Magnesium" title="Magnesium">magnesium</a>, <a href="Strontium.htm" tppabs="https://ptable.com/wiki/compounds/A/Strontium" title="Strontium">strontium</a>, <a href="Zinc.htm" tppabs="https://ptable.com/wiki/compounds/A/Zinc" title="Zinc">zinc</a>)</li>
<li>Dehydroandrosterone</li>
<li><a href="Dihydrotestosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydrotestosterone" title="Dihydrotestosterone">Dihydrotestosterone</a></li>
<li><a href="Estradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estradiol" title="Estradiol">Estradiol</a></li>
<li><small>L</small>-α-Amino acids (incl. <a href="Arginine.htm" tppabs="https://ptable.com/wiki/compounds/A/Arginine" title="Arginine"><small>L</small>-arginine</a>, <a href="Lysine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lysine" title="Lysine"><small>L</small>-lysine</a>, <a href="Ornithine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ornithine" title="Ornithine"><small>L</small>-ornithine</a>)</li>
<li>Osteocalcin</li>
<li><abbr>SHBG</abbr></li>
<li><a href="Testosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testosterone" title="Testosterone">Testosterone</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<dl><dt>See also</dt>
<dd>Receptor/signaling modulators</dd>
<dd>Androgens and antiandrogens</dd>
<dd>Estrogen receptor modulators</dd>
<dd>Progesterone receptor modulators</dd>
<dd>List of androgens/anabolic steroids</dd></dl>
</div></td></tr></tbody></table></div><span>
</span>
<div role="navigation" class="navbox" aria-labelledby="GlaxoSmithKline" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="GlaxoSmithKline" style="font-size:114%;margin:0 4em">GlaxoSmithKline</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Subsidiaries</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>GlaxoSmithKline Pakistan</li>
<li>GlaxoSmithKline Pharmaceuticals Ltd</li>
<li>Stiefel Laboratories</li>
<li>Tesaro</li>
<li>ViiV Healthcare (85%)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Predecessors,<br>acquisitions</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Allen &amp; Hanburys</li>
<li>Beecham Group</li>
<li>Block Drug</li>
<li>Burroughs Wellcome</li>
<li>Glaxo</li>
<li>Glaxo Wellcome</li>
<li>Human Genome Sciences</li>
<li>Recherche et Industrie Thérapeutiques</li>
<li>Reliant Pharmaceuticals</li>
<li>S. E. Massengill Company</li>
<li>SmithKline Beecham</li>
<li>Smith, Kline &amp; French</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Products</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Current</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Pharma</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Advair</li>
<li><a href="Orlistat.htm" tppabs="https://ptable.com/wiki/compounds/A/Orlistat" title="Orlistat">Alli</a></li>
<li>Augmentin</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Rosiglitazone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Rosiglitazone'" tppabs="https://ptable.com/wiki/compounds/A/Rosiglitazone" title="Rosiglitazone">Avandia</a></li>
<li>Beconase</li>
<li><a href="Ibandronic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Ibandronic_acid" title="Ibandronic acid">Boniva</a></li>
<li><a href="Fluticasone_propionate.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluticasone_propionate" title="Fluticasone propionate">Flixonase</a></li>
<li>Hycamtin</li>
<li><a href="Lamotrigine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lamotrigine" title="Lamotrigine">Lamictal</a></li>
<li><a href="Paroxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Paroxetine" title="Paroxetine">Paxil/Seroxat</a></li>
<li>Serlipet</li>
<li><a href="Cimetidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cimetidine" title="Cimetidine">Tagamet</a></li>
<li><a href="Salbutamol.htm" tppabs="https://ptable.com/wiki/compounds/A/Salbutamol" title="Salbutamol">Ventolin</a></li>
<li><a href="Bupropion.htm" tppabs="https://ptable.com/wiki/compounds/A/Bupropion" title="Bupropion">Wellbutrin/Zyban</a></li>
<li><a href="Ranitidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ranitidine" title="Ranitidine">Zantac</a> … <b>more</b></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Vaccines</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Hepatyrix</li>
<li>Pandemrix</li>
<li>Twinrix</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Aquafresh</li>
<li>Horlicks</li>
<li>Nicoderm</li>
<li>Nicorette</li>
<li>NiQuitin</li>
<li>Sensodyne</li>
<li>Tums … <b>more</b></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Former</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>BC Powder</li>
<li>Geritol</li>
<li>Goody's Powder</li>
<li>Lucozade</li>
<li>Ribena</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">People</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Board of <br>Directors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Philip Hampton</li>
<li>Emma Walmsley</li>
<li>Simon Dingemans</li>
<li>Roy M. Anderson</li>
<li>Manvinder Banga </li>
<li>Patrick Vallance</li>
<li>Vivienne Cox</li>
<li>Lynn Elsenhans</li>
<li>Jesse Goodman</li>
<li>Judy Lewent</li>
<li>Urs Rohner</li>
<li>Laurie Glimcher</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Thomas Beecham</li>
<li>Silas M. Burroughs</li>
<li>Mahlon Kline</li>
<li>John K. Smith</li>
<li>Henry Wellcome</li>
<li>Andrew Witty</li>
<li>Chris Gent</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Litigation</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Canada v. GlaxoSmithKline Inc.</i></li>
<li><i>Christopher v. SmithKline Beecham Corp.</i></li>
<li><i>GlaxoSmithKline Services Unlimited v Commission</i></li>
<li><i>United States v. Glaxo Group Ltd.</i></li>
<li><i>United States v. GlaxoSmithKline</i></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Drug Industry Documents Archive</li>
<li>GlaxoSmithKline Prize</li>
<li><i>Side Effects</i></li>
<li>Study 329</li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<ul><li><figure-inline><span><img src="../I/m/Folder_Hexagonal_Icon.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Folder_Hexagonal_Icon.svg.png" data-file-width="36" data-file-height="31" data-file-type="drawing" height="14" width="16"></span></figure-inline> <b>Category</b></li></ul>
</div></td></tr></tbody></table></div>











<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-07-22" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Cimetidine&oldid=968973078  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Cimetidine&oldid=968973078'" tppabs="https://en.wikipedia.org/wiki/?title=Cimetidine&oldid=968973078">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>